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Introduction
Protein–protein interactions  are central to virtually every  cellular process, like DNA
replication, transcription, translation, splicing, secretion, cell cycle control, signal
transduction, intermediary metabolism, in the structure of sub-cellular organelles, transport
machinery across the various biological membranes, packaging of chromatin, network of sub-
membrane filaments, muscle contraction and regulation of gene expression comprise list of
processes in which protein complexes have been implicated as essential components. Due to
importance of these interactions in the growth and development intense research has been
done in recent years. It has emerged that nature has employed in many instances a strategy of
mixing and matching of specific domains that specify particular classes of protein–protein
interactions, modifying the amino acid sequence in order to confer specificity for particular
target proteins.
Protein-protein interactions have a number of different measurable effects some of
them are mentioned as; First, they can alter the kinetic properties of proteins that can be
reflected in altered binding of substrates, altered catalysis and altered allosteric properties of
the complexes. Second, protein-protein interaction is one common mechanism to allow for
substrate channeling. The paradigm for this type of complex is tryptophan synthetase from
Neurospora crasa. Many similar metabolic channeling have been demonstrated, both between
different subunits of a complex and between different domains of a single multifunctional
polypeptide (Srere et al.,1987). Third, protein-protein interactions can result in the formation
of a new binding site. Fourth, protein-protein interactions can inactivate a protein as in case of
interaction of phage p22 repressor with its antirepressor (Susskind et al.,1983), interaction of
trypsin with trypsin inhibitor (Vincent et al.,1972). Fifth, protein-protein interactions can
change the specificity of a protein for its substrate, e.g.  interaction of transcription factors
with RNA polymerase directs the polymerase to different promoters.
Protein interactions may be mediated at one extreme by a small region of one protein
fitting into a cleft of another protein and at another extreme by two surfaces interacting over a
large area. Example for the first case, include protein-protein interactions that involve a
domain of a protein interacting tightly with a small peptide, like interaction of SH2 domain
with a specific small peptides containing a phosphotyrosyl residue. The paradigm for the
second case i.e., surfaces that interact with each other over large areas is that of the leucine
zipper in which a stretch of ∝ helix forms a surface that fits almost perfectly with another ∝
helix from another subunit protein (Ellenberge et al.,1992; O´Shea et al.,1991).
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Regulation of cell functions is delicately balanced by the relative affinities of various
protein partners, modulation of their affinities by the binding of ligands, other proteins,
nucleic acids, ions such as Ca2+ and by covalent modifications like specific phosphorylation
or acetylation reactions. However, within a cell many intracellular and physico-chemical
factors like temperature, ionic strength and pH also play a critical role in protein-protein
interactions. For instance, at high temperature heat shock protein 90 oligomerizes and shows a
new chaperone activity (Yonehara et al.,1996). Ionic strength of a solution affects oligomeric
state of the protein (Brazil et al.,1998; Shima et al.,1998) and also influences the kinetics of
protein interactions. pH plays an important role in stability of protein complexes (Gibas et al.,
1997; Xie et al.,1998).The covalent modification like phosphorylation is well known
phenomenon of regulating protein-protein interaction in signal transduction cascade (Eyster,
1998). 
Specificity of protein-protein interactions
Proteins generally reside in a crowded environment with many potential binding
partners with different surface properties. Most proteins are very specific in interacting with
their partners, although  some are multispecific, having multiple (competing) binding partners
on coinciding or overlapping interfaces. Protein complexes such as hormone-receptor and
antigen-antibody complexes formed between protomers are initially not co-localized, where
as functionally relevant interactions, such as enzyme-inhibitor assemblies are highly specific.
Although, localization has a role to play, specificity clearly derives from the complementarity
of shape and chemistry that determines the free energy of binding. For protein interactions
multi specificity between two homologous families of proteins or between a homologous
family can be distinguished. Multi-specific binding between two protein families is very
common in regulatory pathways or networks such as in extracellular and intracellular
signaling. However, the members of the protein family often recognize a specific pattern or
surface patch on the target protein. For example, the SH2 and SH3 domains bind to proteins
with phosphotyrosine and proline-rich sequences respectively.
Protein interactions are much more widespread as expected. To understand their significance
in the cell it is necessary to identify the different interactions, understand the extent to which
they take place and determine the consequence of the interaction.
1.1 Classes of protein-protein interactions
Proteins interact with other proteins in a number of ways involving number of forces
predominantly non ionic like hydrophobic interactions, Van der Waals interactions. Although
                                                                          Introduction                                                                             3
weak, these forces contribute most to the stability of  a protein complex. Protein interactions
can be also classified as; 
1.1.1 Homo-oligomerization
An enormous number of enzymes, carrier proteins, scaffolding proteins,
transcriptional regulatory factors etc function as homo-oligomers. Incorporation of non-
covalent interactions at the level of protein quaternary structure provides us with a number of
regulatory possibilities that would not be possible if functional unit is comprised of a single
polypeptide chain. Energy can be stored at the subunit interface that can serve to bind ligand,
or modify the protein conformation in response to regulatory ligands. Modulation of subunit
affinity in such a manner need not compromise the folded structure of the protein, yet
provides a considerable energetic margin for modulation of activity. 
1.1.2 Heterologous protein interactions
Communication at the level of the organism or the cell requires the translation of
physical or chemical information signals from one compartment to another. In large part this
communication relies on the specific interaction between particular heterologous proteins in
response to particular chemical or physical signals. Clearly all of the mechanisms have not
been elucidated that control cell functions. 
1.1.3 Non-obligate and obligate complexes 
As well as composition, two different types of complexes can be distinguished on the
basis of whether a complex is obligate or non obligate. In an obligate protein–protein
interaction, the protomers are not found as stable structures on their own in vivo. Such
complexes are generally functionally obligate; for example, the Arc repressor dimer is
essential for DNA binding. Many of the hetero-oligomeric structures in the protein data bank
involve non-obligate interactions of protomers that exist independently, such as intracellular
signaling complexes (e.g. RhoA-RhoGAP) antigen-antibody, receptor-ligand and enzyme
inhibitor (e.g. thrombin-rodnin) complexes. The components of such protein-protein
complexes are often initially not co-localized and thus need to be independently stable.
However, some homo-oligomers, which by definition are co-localized can also form non-
obligate assemblies.
1.1.4 Transient and permanent complexes
Interaction of proteins can also be  distinguished on the lifetime of their complexes. In
contrast to a permanent interaction that is usually very stable and only exists in its complexed
form, a transient  interaction associates and dissociates in vivo. A weak transient interaction
features a dynamic oligomeric equilibrium in solution where the interaction is broken and
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formed continuously and strong transient associations require a molecular trigger to shift the
oligomeric equilibrium. For example, the heterotrimeric G protein dissociation into the G∝
and GβΥ subunits upon guanosine triphosphate (GTP) binding. Structurally or functionally
obligate interactions are usually permanent, whereas non-obligate interactions may be
transient or permanent. 
1.2 Protein interactions in signal pathways
Ability of cells to respond various signals and culminating in multiple cascades of
signal pathways involve interaction between various proteins. These responses are
coordinated through signaling pathways that transduce and exchange information between
different cells or inside the cell between different compartments. Apart from direct cell to cell
contact, signaling to neighboring cells or to distant cells occurs by secreted messenger
molecules such as growth factors and hormones. These molecules bind to their cognate
receptor and there by transmit the signal inside the target cell to finally stimulate a distant
biological response including cell proliferation, migration, differentiation or apoptosis.
Consequently deregulated signal transduction events have been recognized as the underlying
cause of many severe human diseases such as cancer, diabetes, immune deficiencies and
cardiovascular diseases, among many others. Reversible protein phosphorylation has been
identified as a key element in signal transduction processes. Tyrosine kinases and
phosphatases are key proteins in regulating the signal pathway.
1.2.1 Receptor tyrosine kinases (RTKs)
RTKs are transmembrane enzymes responsible for transducing extracellular signals
from peptide growth factors across the cell membrane. They are characterized by extracellular
ligand binding domains, a single transmembrane helix and an intracellular portion containing
tyrosine kinase activity (Robinson et al.,2000). The kinase domain is composed of ∼300
conserved amino acid residues among kinases (Hubbard et al.,2000). It exhibits a two domain
architecture consisting of an amino terminal lobe and a larger carboxy terminal lobe. The cleft
formed by the two lobes harbors the reaction where the γ–phosphate from ATP is transferred
to a hydroxyl group of the tyrosine in the protein substrate. Protein tyrosine kinases can be
subdivided into two families; RTKs and non receptor tyrosine kinases (nRTKs), 58 RTKs and
32 nRTKs are reported (Manning et al.,2002). 
Most RTKs are monomeric in their inactive state and dimerizes upon ligand binding
(Hubbard et al.,1999). One exception is the insulin receptor family, members of which are
dimerized also in the absence of ligands. Ligand binding induces autophosphorylation of
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tyrosine residues in the so called activation loop and subsequently in the residues outside the
catalytic domain. The phosphorylated non-catalytic tyrosine act as specific binding sites for 
downstream signaling proteins containing phosphotyrosine binding (PTB) and Src homology
(SH2) domains. The specificity of individual SH2 domains is determined by the three to five
amino acid residues carboxy-terminal of the phosphotyrosine (Pawson et al.,1997), where as
PTB domain binding specificity motif is conferred by five to eight amino acid residues
amino–terminal of the phosphotyrosine (Songyang et al.,1993).
Activation and interaction of downstream signaling molecules is conferred by different
mechanisms. The activation may involve conformational changes induced directly by the
binding to the RTK and it can also be a consequence of tyrosine phosphorylation. The protein
tyrosine phosphatase SHP-2 and the tyrosine kinase Src are examples of signaling proteins
that undergo conformational changes and subsequent activation upon RTK recruitment.
Activation may also involve translocation of the molecule in proximity to its substrate e.g.
Phosphatidylinositol 3-kinase (PI3 kinase) is recruited to RTKs and thereby translocated to
Mitogen activated protein kinase modules indicating signaling cascade; Each module consists of a
Mitogen activated protein kinase kinase kinase (MKKK), Mitogen activated protein kinase kinase  (MKK) and a
MAPK  (Mitogen activated protein kinase). While the MKKs are relatively specific for  their target, MAPKs,
MKKKs, can activate one or more MKK. Activation of MAPKs induces activation of different targets,
comprising transcription factors but also for instance kinases such as EGFR (Johnson and Lapadat 200)
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the membrane where its substrate phophatidylinositol 4,5 bisphosphate is located. RTKs can
also recruit and phosphorylate transcription factors for instance phosphorylation of STATs
results in dimerization and nuclear translocation of the transcription factors (Xu et al.,1999).
Another group of molecules recruited to activate RTKs is adapter molecules e.g. Shc and
Grb2. 
1.2.2 Protein tyrosine phosphatase (PTP)
Protein tyrosine phosphatase (PTP) is a family of enzymes regulating cellular
phosphorylation state important for many cellular processes (Tonks et al.,1998). PTPs are
biochemically and physiologically distinct from RTKs and are central to regulation of
physiological processes (Hunter,1995) which depends on their subcellular localization (Mauro
et al.,1994; Hunter,1995). PTP family is composed of about 100 enzymes that despite limited
sequence similarity share a highly conserved catalytic signature motif (V/I HCSxGxGR(S/T)
G, at the bottom of an active site cleft (Barford et al.,1998). The cleft confers specificity
towards phosphotyrosine since hydrolysis of the shorter phospho-serine and phospho-
threonine residues is prevented (Guan and Dixon, 1991). PTPs are divided into two major
categories, transmembrane (receptor type) and cytoplasmic (non receptor type). Non receptor
type PTPs contain one PTP domain carrying the PTP activity flanked by domains that are
important for protein-protein interaction and enzyme activity. On the other hand receptor type
PTPs contain one or two PTP domains in the intracellular region which are linked to a variety
of extracellular domains through a transmembrane segment. Non receptor type PTPs undergo
proteolytic cleavage that alter their subcellular localization and can result in their activation
(Gu et al.,1996; Gurd et al.,1999; Nguyen et al.,1995; Rock et al.,1997). Src homology 2
domains of SHP1 and SHP2 mediate recruitment of PTPs to activated growth receptors
(Frangioni et al.,1993; Stein-Gerlach et al.,1998). PTPs functions can be modulated by
interaction between the non–catalytic segment of these enzymes and various binding proteins
(Neel, 1993). Protein-protein interactions have the potential to modulate PTP activity either
by altering enzyme directly or by controlling intracellular localization. 
1.3 Protein interactions at domain level
Many of the signaling pathways and regulatory systems in eukaryotic cells are
controlled by proteins with multiple interaction domains that mediate specific protein-protein
and protein-phospholipid interactions. In this way they determine the biological output of
receptors for external and intrinsic signals. Cytoplasmic proteins conveying information from
cell surface receptors to their intracellular targets are commonly constructed of modular
domains that either have a catalytic function or mediate the interaction of proteins with one
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another, or with second messengers (Pawson,1995). Protein interactions carried out by
domains were originally identified in the context of phosphotyrosine signaling through the
ability of Src homology 2 (SH2) domains of cytoplasmic proteins to recognize specific
phosphotyrosine containing motifs on activated receptor tyrosine kinases (Anderson et
al.,1990; Matsuda et al.,1990; Songyang et al.,1993). During protein–protein interaction
domains not only recognize exposed features of binding partners but also post-translationally
modified sequences (Blaikie et al.,1994; Kavanaugh et al.,1994; Van der Geer et al.,1996),
phosphothreonine/serine–containing elements (14-3-3 proteins FHA,WD40 domains (Yaffe et
al.,2001), phoshphoinositides (PI) (i,e PH, EYVE, PX, ENTH, Ferm) and Tubby domains
(Cullen et al.,2001; Santagata et al.,2001).
1.3.1 SH2 domain in protein interaction
The ability of interaction domains to mediate the formation of protein complexes in a
fashion that depends on protein phosphorylation is typified by the binding of SH2 domains to
phosphotyrosine sites. SH2 domains are protein modules of 100 amino acids that recognize
phosphotyrosine residues-containing peptides in the context of 3-6 carboxy terminal amino
acids (Dilworth et al.,2001) such as those found in the non catalytic region of activated
growth factor receptor, located either between the membrane and the kinase domain or in the
C-terminal loop (Heldin et al.,1998). Such interactions link receptor autophosphorylation to
the activation of specific cytoplasmic signaling pathways. SH2 domains serve as intracellular
targets of RTK and more complex multi-subunit receptors, cytokines and extracellular matrix
components (Schlessinger, 2000; Hunter, 2000). Binding energy for SH2 domain-phospho
peptide interaction comes from its association with phosphotyrosine and also stabilizes the
SH2 mediated complexes (Piccione et al.,1993). In addition, to recognition of
phosphotyrosine SH2 domains recognize three to five residues immediately C–terminal to the
phosphotyrosine in a fashion that varies from one SH2 domain to another (Reedijk et al.,
1992; Waksman et al.,1993; Pascal et al.,1994; Kay et al.,1998). Proteins with more than one
SH2 domain bind with more specificity and affinity with their cognate partners. Thus,
proteins with two tandem SH2 domains bind cooperatively to bisphosphorylated sites
(Ottinger et al.,1998) and Src family kinases can potentially interact with their targets through
both their SH2 domains and the covalently linked SH3 domain, which recognizes proline rich
sequences (Kanner et al.,1991; Nakamoto et al.,1996; Pellicena et al.,2001). SH2 domain of
SH2D1A protein shows apparent flexibility as it can interact not only a phosphotyrosine
residue and more C-terminal amino acids, but also engages atleast two residues N-terminal to
the phosphotyrosine (Poy et al.,1999; Li et al.,1999). There are 111 SH2 domains in the non-
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reductant set of human gene products found in proteins with diverse functions, including
regulation of protein/lipid phosphorylation, phospholipid metabolism, transcriptional
regulation, cytoskeletal organization and control of Ras like GTPase.
1.3.2 PTB domains
PTB domains are characterized through their ability to recognize phosphorylated Asn-
Pro-X-Tyr ß–turn motifs such as found in the RTKs for Nerve growth factor, Insulin or
Epidermal growth factor (Zhou et al.,1995; Trub et al.,1995) and show inherent flexibility for
interaction. Scaffolding proteins with PTB domains like Shc, FRS2 or IRS-1 bind
autophosphorylated receptors positioning these proteins for multisite phosphorylation and
subsequent binding of SH2 domain targets such as Grb2 (for Shc and FRS2) or PI3-kinase
(for IRS-1) (Rozakis-Adcock et al.,1992; Kouhara et al.,1997; Backer et al.,1992). PTB
domains of FRS2 binds to a non phosphorylated peptide ligand found in the FGF receptors
and this interaction is quite different from that exhibited by PTB domain for Asn-Pro-X-pTyr
motifs (Ong et al.,2000; Dhalluin et al.,2000). This  indicates that a PTB domain can bind
Modulator interaction domains as building blocks in signal transduction. Interaction domains
bind proteins, phospholipids of nucleic acids. A subset of such domains is illustrated and their general
binding functions are indicated ( Pawson and Nash   2003)
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both phosphorylated and non phosphorylated motifs. Due to flexible scaffold structure
proteins with PTB domains mediates a wide range of protein-protein and protein-phospholipid
interactions (Blomberg et al.,1999; Forman-Kay et al.,1999; Prehoda et al.,1999; Pearson et
al., 2000).
1.3.3 Domains recognizing phosphoserine/ threonine 
Large number of domains bind to phosphoserine/threonine containing motifs
suggesting that protein phosphorylation is a rather general way of regulating protein-protein
interactions (Yaffe et al.,2001), first recognized in the context of 14-3-3 proteins, which binds
motifs such as Arg-Ser-X-pSer-X-Pro (Muslin et al.,1996; Tzivion et al.,2001) and has more
recently been described for FHA domains,which are found in proteins that regulate the DNA
damage response (i.e. Rad 53, Chk2), gene expression (Forkhead proteins) and protein
trafficking (kinesins) (Durocher et al.,1999; Durocher et al.,2000). FHA domains bind
preferentially to phosphothreonine motifs, and recognize the +3 residue relative to the
phosphothreonine in a fashion that differs from one FHA domain to another any may impart
biological specificity. FHA domain is similar to MH2 domains found at the C-terminus of
Smad proteins, the targets of TGF ß-receptor serine /threonine kinases (Wu et al.,2000).
1.4 Nuclear receptors as transcription factors
Nuclear receptors (NR) as transcription factors play an important role in growth,
development, homeostasis, reproduction and disease processes (Mangelsdorf et al.,1995;
Whitfield et al.,1999). As, ligand activated transcription factors, NR provide a direct link
between signaling molecules that control these processes and transcriptional responses. NR
form a superfamily of phylogentically related proteins with 21 genes in the complete genome
of Drosophila melanogaster (Adams et al.,2000), 48 in humans (Robinson-Rechavi et
al.,2001)  [but one more, FXRß, in the mouse (Robinson-Rechavi and Laudet, 2003)] and
unexpectedly, more than 270 genes in Caenorhabditis elegans (Sluder et al.,1999). The
superfamily includes the classic steroid receptors (androgen, estrogen, glucocorticoids,
mineralocorticoids and progestrone receptors), thyroid receptors, vitmain D and retinoid
receptors. NR share common functional domains that includes a ligand-binding domain, a
DNA-binding domain (consisting of two zinc fingers) and two domains that are involved in
transactivation of genes (Beato et al.,1995). NR regulate transcription by binding their
cognate lipophilic ligands and subsequently undergo a conformational change that alters their
ability to interact with regulatory proteins. which may lead to repression, depression or
activation of transcription. In case of  activation, NR recruit coactivators (discussed in detail
separately), which lead to acetylation and hence condensation of the chromatin and
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subsequently other coactivator protein complex bind the receptor and interact with the basal
transcription machinery to initiate transcription (Lemon et al., 2000; Rachez et al., 2001;
Glass et al.,2000; Freedman et al.,1999). Ligand bound NR interact with cognate binding site
called hormone response element (HRE) to affect the transcription of target genes. HREs are
composed of two hexameric half–site core sequences (Aranda et al.,2001) and diversity
among HREs is achieved by modifying the location of the half–sites relative to one another. 
1.4.1 Coactivator recruitment by nuclear receptors
Coactivators are different from the general transcription factors in that most of them
do not directly bind to the DNA but are associated with the promoter region via a gene
specific activator molecule like NR. Over 30 potential coactivators have been identified by
their ability to bind and alter the transcriptional activity of ligand activated NR (Wallberg et
al., 2000). Steroid receptor coactivator (SRC-1) is the founding member of SRC family of
coactivators (Onate et al.,1995), which also includes transcriptional intermediary factor–2
(TIF2, 42,43 M9 and receptor associated coactivators-3  (Li et al.,1997; Anzivk et al.,1997;
Chen et al.,1997; Torchia et al.,1997).
Two distinct steps in target gene activation turn up to be regulated by coactivators. Firstly,
coactivators remodel the chromatin structure of the promoter region in order to facilitate
binding of other activators and the component of the RNA polymerase II transcriptional
machinery. Secondly, coactivators recruit protein complexes (mediator complex) that interact
with one or more subunits of the RNA polymerase II and enhance the initiation of
transcription by stabilizing the preinitiation complex (PIC) (Naar et al.,2001).
There are two general classes of enzymes complexes that appears to a play critical role
in nucleosome remodeling mediated transcriptional activation. These are;
1. Histone acetyl transferase (HAT) which regulate nucleosome structure by altering the
histone acetylation pattern of core histone tails (Sterner et al.,2000)
2. ATP-dependent chromatin remodeling factors (Sudarsanam and Winston, 2000;
Varga–Weisz, 2001). 
Histone acetyltransferases are the best characterized group of enzymes that covalently
modify the structure of chromatin. They acetylate basic lysine residues located at the N-
terminal tail of histones (Sterner and Berger, 2000). The acetylation of histones is thought to
reduce electrostatic interactions between histones and DNA (Hong et al.,1993) and between
separate nucleosome particles leading to the destabilization of the higher-order folding of
chromatin (Tse et al.,1998). Acetylation might also disrupt the secondary structure of histone
N-termini, which might further destabilize interaction with DNA and the nucleosome itself
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(Hansen et al.,1998). Additionally, it has been shown that acetylation of specific lysine
residues in the core histones provides novel recognition surface for proteins having
bromodomain structures. This lead to the conclusion that, histone acetylation may enhance the
initiation of transcription by two distinct mechanisms: by remodeling the structure of
nucleosomes which leads to increased access of transcription factors to the promoter and by
creating the specific binding sites for bromodomain containing transcriptional co regulators
such as TFIID and SWI/SNF (DiRenzo et al., 2000; Hassan et al.,2000; Jacobson et al.,2000;
Syntichaki et al.,2000). A number of coactivators that are recruited by activated NRs contain
intrinsic HAT activity including the p160 family of coactivator’s also known as steroid
receptor coactivators (SRC) (Leo and Chen, 2000) and general coactivators CBP/p300 and
PCAF (Yao et al.,1996). The p160 family coactivators communicate with virtually all NR in a
hormone dependent manner, suggesting a common pathway of hormone-induced gene
activation among the NR family (McKenna et al.,1999; Leo et al.,2000). The p160 proteins
bind to the LBD of nuclear receptors via receptor interacting domain, which contains three
short LXXLL binding motifs (where L is leucine and X is any amino acid). These motifs are
conserved in both sequence and spacing and their number varies from one coactivator to
another (Heery et al.,1999; Le Douarin et al.,1996; Rachez et al.,1998;Torchia et al.,1997).
Analysis of these motifs has revealed that they form amphipathic α-helices with the leucine
residues forming a hydrophobic surface on the face of the helix. Although the different
receptors bind the common LXXLL motif in coactivators, there is receptor specific
differential utilization of these motifs. Whereas a single motif of SRC-1 coactivator is
sufficient for activation by ER, different combinations of two appropriately spaced motifs are
Coactivator recruitment; Ligand binding induces conformational changes in the ligand binding
domain (LBD) of receptor and exposes coactivator docking site on LBD. Coactivators interact with the
receptor on these exposed sites via specific LXXLL motifs present in coactivators  (Pike et al.,2002)
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required for activation by TR, RAR and androgen receptor (AR). LXXLL binding motifs are
needed for cooperative interaction with NR dimer (Darimont et al.,1998; Shiau et al.,1998;
Wisely et al.,1998). The mechanism of interaction seems to be receptor specific and several
combinations of LXXLL binding motifs are differently required for interaction with the
different composition of NR dimers (Darimont et al.,1998; Mak et al.,1999; Heery et
al.,2001). Recently, Zor et al.,2004 and Razeto et al.,2004  reported that there are differences
in the binding mode of the LXXLL motif with the NR and non nuclear receptor based
complexes.
In addition to having enzymatic HAT activity p160 family of coactivators have an
important role as platform molecule which recruits other proteins such as CBP/p300 and
PCAF complexes. CBP/p300 is one of the most potent acetyl transferases. Unlike p160 family
members, CBP/p300 is able to acetylate all four histones within nucleosomes and it is able to
communicate with numerous promoter–binding transcription factors such as CREB, NRs,
STATs, Ets, c-Fos, c-Jun and c-Myb. Therefore, CBP/p300 could be seen as a global
coactivator in higher eukaryotes (Ogryzko et al.,1996; Yang et al.,1996). 
Mechanism of action of p160 nuclear receptor coactivators. A two-step mechanism has been proposed
for p160 proteins mediate nuclear hormone receptor transcriptional activation. As an initial step, HAT activity of
the recruited coactivator complex modulates local chromatin structure resulting in general transcription factors
gaining access to DNA at the promoter. This step is followed by recruitment or stabilization of the RNA
polymerase II holoenzyme (pol II) through direct or indirect binding of coactivators with general transcription
factors associated with pol II. The high mobility group protein HMG-1/-2 enhances transcription by facilitating
steroid receptor binding to specific hormone response elements and stabilizing the receptor–DNA complex
(Edwards,  1999). [Abbreviations; DBD, DNA binding domain, AF-1/2, activation factor 1/2, HAT histone
acetyltransferase, (HMG), high mobility group, HRE, hormone response elements ]
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In addition to histone acetylation CBP /p300 can also acetylate non-histone proteins such as
p160 family of coactivators, transcription factors such as p53 and components of general
transcription machinery such as TFIIE and TFIIF (Sterner and Berger, 2000). This acetylation
mechanism is thought to mediate the autoregulation of coactivation process e.g. it is
documented that the acetylation of lysine residues of p160 proteins in the vicinity of the
LXXLL motif abolishes p160 coactivator interaction with NR, which in turn causes the
dissociation of coactivator complex including p300/CBP from the receptor and target gene
promoter leading to the attenuation of transcription (Chen et al.,1999). Thus CBP/p300 could
have a dual role firstly to catalyze histone acetylation required for gene activation and
secondly to attenuate the process by acetylating p160 proteins (Bevan and Parker,,1999).
1.4.2 Coactivators in chromatin remodeling 
SWI/SNF, ISWI, CHD and MI-2 complexes form another important class of
coactivators involved in NR mediated chromatin remodeling (Dilworth et al.,2000; DiRenzo
et al., 2000;Varga-Weisz et al.,2001). SWI/SNF and ISWI are the best characterized ATP-
dependent remodeling complexes. Unlike HATs, these complexes do not carry out covalent
modification of histones. Instead they catalyze the uncoupling of ionic interactions between
histones and DNA using the energy supplied by ATP hydrolysis. They are able to alter
nucleosome conformation by sliding histone octamers to another site on the DNA or by
changing the helical torsion of the DNA twist (Havas et al.,2000; Sudarsanam and Winston ,
2000; Fry et al.,2001). A novel multifunctional ATP-driven chromatin remodeling complex
called WINAC that interacts with  vitamin D receptor (VDR) was described by Kitagawa et
al.,2003.
1.5 Modulation in protein–protein interaction
Precise protein–protein interaction is utmost important to carry out their normal
functions. Any  aberration in normal protein interaction leads to number of diseases and other
abnormalities e.g. regulation of proteolysis is critical for the healthy function of the cell
excessive proteolysis leads to diseases like emphysema, thrombosis, rheumatoid arthritis and
hyper fibrinolytic hemorrhage (Stein et al.,1995; Whisstock et al.,1998), while incomplete
proteolysis can be seen as a cause in Alzheimer’s disease (Moir et al., Caswell et al.,1999),
psorisis (Abts et al.,1999) tumor development (Suminami et al.,2000) and infection by
parasites and nematodes (Zhang et al.,2001). Many approaches have been developed to study
and interrupt the abnormal interaction between proteins. Some of the approaches are as;
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1.5.1 By use of synthetic molecules
Modulation of protein-protein interaction by synthetic molecules that can bind a
protein surface is still a major challenge (Hartwell et al.,1997) due to difficulty in matching
the unsymmetrical distribution of polar and non polar domains on the protein as well as
covering a sufficiently large surface area to achieve high affinity. However, for some proteins
with a cleft or cavity molecules have been designed e.g guanidine esters, bind to IL2 and
block its interaction with its heterotrimeric receptor complex (Tilley et al.,1997). Small
heterocylces bind to CD 4 and disrupt its binding to MHC class II proteins on the surface of
antigen presenting T cells (Huang et al.,1997). Park et al.,2002 have developed a strategy to
recognize protein surface by designing molecules that contains a large funtionalized and
variable interaction surface (Hamuro et al.,1997) to disrupt the interaction between serine
proteases and their proteinaceous inhibitors (PIs). Anionic polymers or oligomers such as
aurintricarboxylic acids, heparin derivatives and oligophenoxyacetic are used to target
charged regions on a protein surface.
1.5.2 By use of naturally organic molecules 
Number of naturally occurring organic molecules have been used to target protein–
protein interactions. Taxane agents like paclitaxel (Taxol) (Rowinsky et al.,1997), [a
diterpenoid isolated from the bark of pacific yaw tree] and its semi-synthetic derivative
docetaxol, bind to ß–subunit of the tubulin hetrodimer and there by stabilizes interaction
between the tubulin heterodimers. They are used in a number of human cancers. Laulimalide
(Moobery et al.,1999), epothilones A and B (Bollag et al.,1995), eleutherobin and
discodermolide (ter Haar et al., 1996) are among natural organic molecules used to stabilize
microtubules. Brefeldin A, a fungal metabolite stabilizes protein interaction between
guanidine diphosphatase bound proteins of Ark family and Sec7 domains (Peyroche et al.,
1999). FK1012 (Spencer et al.,1993), (a dimer form of naturally occurring small molecule
FK506) and cyclosporin A (Belshaw et al.,1996) induce dimerization of genetically
engineered receptors and consequently induce signal transduction and specific target–gene
activation (Spencer et al.,1996). FK506 and rapamycin reconstitutes activity of transcriptional
factors, whose functional domains had been separated and linked to the ligand–binding
proteins of these organic molecules (Rivera et al.,1996).
1.5.5 By use of peptides
Peptides derived from the protein interaction surfaces have been reported by several
workers to inhibit the protein interactions. Zhang et al.,1991 reported that the tetrapeptide Ac-
Thr-Leu-Asn-Phe-COOH derived from the C-terminal of HIV-1 protease inhibits the protease
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by dissociative mechanism. Zutshi et al.,1998 used a peptide derived from the N-termini of
HIV-1 protease cross linked by a sequence from C-terminal to inhibit the protease.
Ribonucleotide reductase is important for Herpes simplex virus for its virulence and
reactivation from latency  (Jacobson  et al.,1989). This enzyme is active when its two subunits
interact each other. Discovery of a hexapeptide Ala-Val-Val-Asn-Asp-Leu (Krogsrud et al.,
1993) inhibits enzymatic activity of ribonucleotide reductase by preventing association
between the two enzymatic subunits. Tumor suppressor protein p53 is suppressed in majority
of human tumors. In about 30% of sarcomas, Hdm2 protein interaction with p53 inhibits its
activity by two different mechanisms; first Hdm2 binds to the transcriptional activation
domain of p53 and thereby inhibits expression of p53 target genes, second a protein complex
involving Hmd2 mediates nuclear export of p53 and subsequent degradation of p53 by
cytoplasmic proteasomes (Freedman et al.,1999). Phage display has revealed that peptides of
varying lengths (10-14 amino acid) could disrupt the interaction between p53 and Hdm2. In
addition a cyclic nonapeptide composed of natural and unnatural amino acids also inhibits this
interaction. Function of transcription factor E2F, a crucial cell cycle regulator controlling
G1/S transition (Muller et al., 2000) was effectively shown to be antagonized by the peptides
by blocking its binding to DNA target sequence and there by inhibiting E2F–dependent
transcription (Fabrizzio et al.,1999).
1.5.4 Low molecular weight modulators (Identified by screening of chemical libraries)
Screening chemical libraries could identify a number of modulators of protein
interaction. Anti-apoptotic bcl-2 family genes bcl-2 and bcl-xl  whose over expression provide
resistance to the tumors  to chemotherapy (Gutierrez-Puente et al.,2002) and prevent
apoptosis by inhibiting the function of other pro-apoptotic members of the Bcl-2 family, such
as Bax and Bak, by binding to their BH3 (Bcl-2 homology 3) domain.  Degterev et al., 2001
set up an in vitro assay based on fluorescence polarization to prevent this interaction by
identifying small molecules by screening a chemical library comprising of 16320 chemicals.
Three compounds termed as BH3I-1, BH3I-1´and BH3I-2 were identified to interrupt this
interaction. Interaction of transcription factor c-Myc with Max (Amati et al.,1993) is known
to be cause of one out of 7 human cancer deaths. On screening a chemicals library
encompassing approximately 7000 compounds four active compounds were identified to
modulate this interaction (Boger et al.,2000; Menssen et al.,2002; Brooks et al.,1996). Carter
et al., 2000 identified N-alkyl 5 arylalkylidine–2 thioxo-1,3 thiazolidine 4-ones as an
antagonist for the TNFx/TNFRcI (tumor necrosis factor/Tumor necrosis factor receptor I) 
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interaction on screening chemical to interrupt this interaction which is known to be a cause of
various autoimmune diseases like rheumatoid arthritis or Crohn´s disease (Risau, 1997). 
1.5.5 By mutation
Protein-protein interactions are highly specific although some proteins are
multispecific. A mutation in anyone of the interacting partners may disrupt their interaction.
Shiu et al., 1996 created a mutation in CREB that prevented its association with coactivator
CBP. However, not all mutations lead to a disruption in the interaction, but also might
enhance interaction between them. Human T-cell leukemia virus protein Tax does not interact
directly with serum response factor (SRF) (Fujii et al.,1992; Suzuki et al.,1993). Mutations
created in Tax activate c-fos promoter through SRE (Fujii et al.,1988) a process possible only
from a direct interaction between Tax and SRF. 
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Aim of the study 
 
Protein-protein interactions play a key role in cellular processes. Their specificity is 
instrumental for signal transduction and gene regulation, which govern cell growth, 
proliferation, differentiation and programmed cell death, as well as for basic metabolism and 
other biochemical processes. In all cases protein-protein interactions can be activating or 
inhibiting. They may be exclusive or with varying partners and may be the basis for the 
formation of large complexes comprised of many interaction partners. The latter is of 
particular interest because many proteins contain a range of domains suitable for different 
specific interactions enabling these proteins to interact with many partners and participate in 
various processes. Given this general importance, protein interactions are studied at various 
levels using a wide range of analytical methods, which mostly do not allow to assign specific 
activities to individual interactions or interaction domains in vivo.  
The main aim of the project was to develop a tool to interfere with one specific protein 
interaction at a time in vivo. For this, a peptide expression vector system had to be be 
developed that allows the expression of small peptides in mammalian cells, which to ensure 
expression can be monitored with an unlinked fluorescent protein. This system should be so 
versatile that very small peptides can be presented with the same efficiency as somewhat 
larger peptides with and without flanking sequences for stabilization. In addition, the system 
should allow expression of random peptide libraries containing a large number of different 
unrelated peptides, which can be used for in vivo selection protocols.  
This aim can be broken into the following developmental steps each representing an 
interesting scientific question of its own. These are: which vector system can be used for 
efficient expression of short peptides; disruption of known protein-protein interactions to 
establish the basic protocol and verify if the design of the expression vector system is 
appropriate; disruption of a protein-protein interaction in the nucleus to demonstrate that 
peptides also function in the nucleus; and finally selection of a novel bioactive peptide by in 
vivo selection from a random peptide library expression system. 
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Material and methods
2.1.1 Chemicals
Agarose Roth, Karlsruhe
Agar      Roth, Karlsruhe
Ampicillin Gibco/BRL, Karlsruhe
ATP (adenosine 3´-triphosphate) MBI Fermentas
Anhydrotetracycline  Acros Organics, 
Leicestershire
Bromophenol blue Roth, Karlsruhe
Chloroquine Sigma, Deisenhofen
Deoxynucleotides (dG/A/T/CTP) MBI Fermentas,
St.Leon-Rot 
Dimethyl sulfoxide (DMSO) Sigma, Deisenhofen
Ethidium bromide Sigma, Deisenhofen
Effectene Qiagen, Heldin
Polybrene  Sigma, Deisenhofen 
9-cisretinoic acid Sigma, Deisenhofen
Penicillin/streptomycin Gibco/BRL, Karlsruhe
Nerve growth factor Biomol, Hamburg 
Vitamin D Biomol, Hamburg
2.1.2 Enzymes
Alkaline phosphate MBI Fermentas, 
St.Leon-Rot
Restriction endonucleases MBI Fermentas,
St.Leon-Rot
NEB, Frankfurt
T4 DNA ligase MBI Fermentas
St.Leon-Rot 
Taq-DNA polymerase Sigma, Deisenhofen
Trypsin Gibco/ BRL, Karlsruhe
2.1.3 Kits and other materials
Qiagen mini prep kit Qiagen, Hilden
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Qiagen maxi prep kit Qiagen, Hilden
Endofree plasmid kit Qiagen, Hilden
Effectene transfection kit  Qiagen, Hilden
Gel extraction kit Qiagen, Hilden
PCR purification kit Qiagen, Hilden
Great EscAPe TM SEAP
chemiluminescence detection kit Clontech, Heidelberg
Sterile filter 0.45µm, cellulose acetate free Nalgene, Rochester
Luminometer BMG, Offenburg
2.2 Media and buffers
2.2.1. Medium for E. coli
LB-Medium 1.0% Tryptone
0.5% Yeast extract
1.0% Nacl
pH 7.2
Ampicillin 100µg/mL was added to the media after autoclavation.
LB-plates additionally contained 1.5% Agar.
2.2.2 Cell culture media
All cell culture media and addictives were from Gibco/BRL, Fetal calf serum (FCS),
Dulbecco´s modified eagle medium (DMEM) with 4.5mg/mL glucose, 2mM L-glutamine,
1mM sodium pyruvate.
Freeze medium: 90% heat inactivated FCS, 10% DMSO
2.2.3 Stock buffers
DNA loading buffer (6x) 0.25% Bromophenol blue
0.25% Xylencyanol
30.0% Glycerol
100.0mM EDTA pH 8.0
PBS 13.7mM Nacl
2.7mM KCL
80.9mM Na2HPO4
1.5mM KH2PO4, pH 7.4
TAE (10x) 400mM Tris/acetate
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10mM EDTA
pH 8.0 (Acetic acid)
PCR (10x) 100mM Tris-HCl, pH 8.8 at 250C
500mM KCl
0.8% Nonidet P40
15mM MgCl2 
KCM (5x)  500mM KCl
150mM CaCl2 
250mM MgCl2
Lysis Buffer 20mM Hepes pH7.5
10mM EGTA
40mM ß-glycerophosphate
2.5mM MgCl2
1% NP-40
* Protease inhibitor cocktail was added to the lysis buffer at the time of lysis of cells
Digestion Buffer 100mM Nacl
10mM Tris-Hcl pH 8
25mM EDTA pH 8
0.5% (w/v) SDS
0.1mg/mL Proteinase K
* Proteinase K was added fresh every time to buffer. 
2.3 Bacterial strains and cell lines
2.3.1 Bacterial strains 
E.coli     Description
Top 10 F´  F´lacITn10 (TetR)mcrA∆(mrr-hsdRMmcrBC)
                                       φ80lacZ∆M15 ∆lacX74recA1araD139 ∆(araleu)
                                              7697galUgalK rpsLendA1nupG
DH5aF´ F´/endAI hsd 17 (rk-mk-) supE44, recAI, gyrA
             (NaI), thi-I,
2.3.2 Cell lines
Cell lines Description
HeLa                        Human cervix carcinoma, epithelial-like 
     cells growing in monolayer  
                                                                  Material and methods                                                                            21
NIH3T3            Swiss mouse embryo, fibroblast, adherent 
                                               monolayer
NIH3T3TrkA-Ros   Modified NIH3T3 cell line, expressing TrkA                                         
                                                            domain and SHP-1 (phosphatase)
Ecopack 293                    Human embryonic kidney (HEK-293) fibroblast                                  
derived packaging cell line.
2.4 Methods in molecular biology
2.4.1 Plasmid preparation for analytical purpose
Small amounts of plasmid DNA were prepared as described by (Lee and Rashid,
1990). Plasmid preparation for mammalian cells, DNA of high quality was prepared using
Qiagen maxi-kit and Qiagen Endofree maxi kit (Qiagen) according to manufacturer’s
protocol. 
2.4.2 Digestion of DNA samples with restriction endonucleases
Restriction endonuclease cleavage was accomplished by incubating the enzyme(s)
with the DNA in appropriate reaction condition. The amounts of enzyme, DNA, buffer, ionic
concentrations and the temperature, duration of the reaction were adjusted to the specific
application according to the manufacturer’s recommendations.
2.4.3 Dephosphorylation of DNA 5´-termini with calf alkaline phosphatase (CIAP) 
Dephosphorylation of 5´-termini of vector DNA in order to prevent self-ligation of
vector termini was carried out by CIAP. For dephosphorylation required amount of DNA
termini were dissolved in 44µL of deionized water, 5µL 10x reaction buffer (500mM
Tris/HCL pH 8.0, 1mM EDTA pH 8.5) and 1µL CIAP (1U/µL). The reaction mixture was
incubated at 37OC for one hour and stopped by heating at 65OC for 15 minutes.
2.4.4 DNA insert ligation into vector DNA
T4 DNA ligase catalyzes the formation of a phosphodiester bond between juxtaposed
5´-phosphate and 3´-hydroxyl termini in duplex DNA. In a total volume of 10µL the digested,
dephosphorylated and purified vector DNA (200ng), the foreign DNA to be inserted, 1µL T4
DNA ligase (2U for sticky ends and 4U for blunt ends) were mixed. The reaction mixture was
incubated at 16OC overnight. T4 DNA ligase was inactivated by heating the reaction mixture
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at 65OC for 10 minutes. The resulting ligation reaction mixture was directly used for bacterial
transformation.
*Note: Concentration of DNA and insert in addition to mention above was varied in
some cloning experiments.
2.4.5 Phosphorylation of DNA by T4 polynucleotide kinase 
T4 polynucleotide kinase (T4PNK) is a polynucleotide 5’-hydroxyl kinase that
catalyzes the transfer of the phosphate from ATP to the 5`-OH group of single and double
stranded DNAs, RNAs, oligonucleotides or nucleoside 3’-monophosphates (forward
reaction). In the presence of ADP, T4PNK exhibits 5’-phosphatase activity and catalyzes the
exchange of terminal 5'-phosphate groups (exchange reaction). 
In a total reaction mixture of 20µL DNA fragment to be phosphorylated, 2µL of
T4PNK (10U/µL), 2µL (10x) T4PNK buffer (500mM Tris-HCl pH 7.6 at 25°C, 100mM
MgCl2, 50mM DTT, 1mM spermidine and 1mM EDTA), adenosine triphosphate
(ATP) 1µL were mixed. Reaction mixture was incubated at 37OC for half an hour. T4PNK
was inactivated, by incubating at 68OC for 10 minutes.
2.5 Agarose gel electrophoresis
Agarose gel electrophoresis was used for separating and identifying DNA fragments.
0.5x TAE or TBE electrophoresis buffers were used for separation. The voltage was set
typically to 1-10 V/cm of gel. Gels were stained by covering the gel in a dilute solution of
ethidium bromide (0.5µg/mL in water) and gently agitating for 30 minutes or by adding
ethidium bromide directly to the gel solution.
2.5.1 Isolation of DNA fragments using low melting temperature agarose gels
Following preparative gel electrophoresis using low melting temperature agarose, the
gel slice containing the band of interest was removed from the gel. This agarose slice was
then melted and subjected to isolation using the QIAquick gel extraction kit (Qiagen).
2.5.2 Polymerase chain reaction (PCR)
The following standard protocol was adjusted to the specific application;
In a total 50µL of reaction mixture DNA to be amplified, set of primers (sense and antisense
20pmoles each), dNTPs 1µL (10mM each), 10X PCR buffer (100mM Tris/HCl pH 8.8 at
250C, 500mM KCl, 0.8% Nonidet P40, 15mM Mgcl2) and 1µL of Taq polymerase (5U/µL)
were mixed. The reaction was carried out as follows
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950C  5 minutes  (first denaturation)
950C 30 seconds  (denaturation
560 C 40 seconds (hybridization)
72OC 45 seconds (extension)
Amplification 30 cycles
72OC 10 minutes (last extension)
*Note: Temperature, time of hybridization and extension steps were adjusted as per the need
of experiment.
10µL from each reaction were electrophoresed on an agarose gel appropriate for the PCR
product size expected.
2.5.3 PCR product purification 
DNA fragments obtained by PCR were purified by PCR purification kit (Qiagen)
before cloning or sequencing to remove nucleotides and enzyme following the manufacturer's
recommended protocol.
2.5.4 Phenol chloroform precipitation
Restriction enzyme digested DNA, PCR products were purified and concentrated by
phenol/chloroform precipitation as follows;
To a reaction mixture, add equal amount of phenol/chloroform, vortex, and centrifuge at
12,0000rpm for 5 minutes at 40C. Supernatant carefully taken into another tube and first step
repeated. Aqueous layer taken into new tube, one-tenth volume of 3M NaoAc pH 5.2 and two
volume of 100% ethanol were added. Reaction mixture was kept at –200C for 30 minutes and
centrifuged at 40C for 20 minutes at 13,000rpm, followed by washing with 70% ethanol.
Dissolve the pellet in appropriate volume of water or TE buffer.
2.6 Introduction of plasmid DNA into E.coli cells
2.6.1 Preparation of competent cells
Competent cells were made according to the procedure described by (Chung et al.,
1988). For long term storage competent cells were frozen at –80OC. Transformation
frequency ranged between 106 and 107 colonies /µg DNA.
2.6.2 Transformation of competent cells
Reaction mixture comprising of 10µL ligation mixture, 20µL 5x KCM buffer (500mM
KCL, 150mM CaCl2, 250mM MgCl2) 70µL of H2O were added to 100µL of competent cells
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and incubated on ice for 30 minutes, followed by incubation for 10 minutes at room
temperature. 1mL LB medium with out antibiotic was added to cells and incubated for 1hour
at 370C with mild shaking to allow expression of the antibiotic resistance gene. Transformants
were selected on appropriate plates. 
2.7 Vectors 
pLNHX (Clontech) is a part of pantropic retroviral vector designed for efficient gene
delivery and expression.
pIRES-EYFP (Clontech) is an IRES bi-cistronic vector with enhanced yellow
fluorescent protein as a  reporter
pCRE-SEAP (pCRE) vector has three copies of the cAMP response binding element
(CRE) sequence fused to a TATA-like promoter (PTAL) region from the herpes simplex virus
thymidine kinase (HSV-TK) promoter and Secreted enhanced alkaline phosphatase (SEAP)
gene as a reporter.
pGRE-SEAP (pGRE) vector has three tandem copies of Glucocorticoid response
element (GRE) sequence fused to a TATA-like promoter (PTAL) region from the Herpes
simplex virus thymidine kinase (HSV-TK) promoter and Secreted enhanced alkaline
phosphatase (SEAP) gene as a reporter.
pTAL-SEAP vector was modified by introducing vitamin D response element
(VDRE ) in the multiple cloning site.
pOS IRESGFP, bi-cistronic retroviral vector with green fluorescent protein as a
marker.
2.7.1 Vector constructs
pLNHX is a part of pantropic retroviral vector designed for efficient gene delivery and
expression. Retroviral vector constructs are based on the pLNHX vector. Drosophila heat
shock promoter Phsp70 was replaced by human cytomegalovirus (CMV) major immediate
early promoter, excised from pIRES-EYFP vector. 
5´LTR Ψ Neo CMV IRES EYFP 3´LTRSfi1 Sfi1
peptide
Schematic structure of pLNHX retroviral vector indicating site of cloning short peptides,
restriction enzymes employed and various vector constituents.
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Nsi1 and BsrG1 restriction sites were introduced into the multiple cloning site of pLNHX,
employed to insert Internal Ribosome Entry Site (IRES) and Enhanced yellow fluorescent
protein (EYFP) gene as a single fragment, vector was renamed as pLNHX IR-EY. Two Sfi1
sites with different overhangs were introduced in the multiple cloning sites (MCS) of pLNHX
IR-EY vector before the IRES sequence to allow efficient directional one step cloning of
peptide coding oligonucleotides.
2.7.2 Oligonucleotides coding for short peptides
  Various oligonucleotides coding for short peptides were cloned in the pLNHX IR-EY
vector .Two sequences were chosen. One is called as Pos peptide sequence (Pos) it is 13
amino acid sequence derived from Ros tyrosine phosphorylation domain with specific
tyrosine residue needed for interaction with SHP-1 protein tyrosine phosphatase (SHP-1PTP).
The other peptide is called as Neg peptide sequence (Neg) having a single point mutation
which replaces tyrosine by phenylalanine and thus making it no more a binding partner for
SHP-1PTP. In addition to this, another peptide of random sequence was taken as a control
peptide having no specific sequence similarity with Ros tyrosine domain. This peptide was
referred as nonspecific peptide (NSP).
Oligonucleotides used for Pos peptide sequence (Pos)
5´aggccatggagggtcttaattatatggttcttgctactaaatcttcctaaggcctgct 3´
5´ aggccttaggaagatttagtagcaagaaccatataattaagaccctccatggcctgag 3´
Oligonucleotides used for Neg peptide sequence (Neg)
5´aggccatggagggtcttaattttatggttcttgctactaaatcttcctaaggcctgct 3´
5´ aggccttaggaagatttagtagcaagaaccataaaattaagaccctccatggcctgag 3´
2.7.3 Annealing of oligonucleotides
For annealing 50pmoles from each oligonucleotide were mixed in 50µL of annealing
buffer or water, incubated at 900C for 10 minutes, cooled and subsequently phosphorylated
before cloning in pLNHX IR-EY vector at Sfi1 restriction site. Vector with Pos was renamed
as pLNHX IR-EY Pos, vector with Neg was renamed as pLNHX IR-EY Neg and vector with
NSP was renamed as pLNHX IR-EY NSP.
2.7.4 Addition of self-annealing flanking clamp sequence 
A self-annealing clamp sequence was added to Pos and Neg peptide sequences on both
N and C termini. Self-annealing flanking sequence (EFLIVIKS) as reported by (Gururaja et
al., 2000) forms a stable dimer and protects the peptide from proteases.
                                                                  Material and methods                                                                            26
Pos peptide with self-annealing clamp is designated as (PC) and Neg peptide with self-
annealing clamp sequence as (NC).
Oligonucleotides used for PC
5´gatccggccactcaggccatgggcgagttcttgatcgtgataaagtcaggg 3´
5´gataaggaattctccggaagatttagtagcaagaaccatataattaagaccctccatccctgactttatcacgat 3` 
5´gatccggcctagcaggccaatcaggttttaaggaggccctgatttgatgacgataaggaattctcc 3 ´
Oligonucleotides used for NC
5´gatccggccactcaggccatgggcgagttcttgatcgtgataaagtcaggg 3´
5´gataaggaattctccggaagatttagtagcaagaaccataaaattaagaccctccatccctgactttatcacgat3 
5´gatccggcctagcaggccaatcaggttttaaggaggccctgatttgatgacgataaggaattctcc 3´
PC and NC encoding oligonucleotides were cloned in pLNHX IR-EY vector and
vectors were renamed as pLNHX IR-EY PC and pLNHX IR-EY NC respectively. Three
oligos were used for PC and NC, each having atleast 15 to 18 bases complementary to one
other. For PC, 10pmoles from all three oligonucleotides were mixed in 40µL of water used as
a template for PCR. 10-15 cycles of PCR were carried out. Three bands were seen on the
agarose gel, band of required size was excised, amplified using appropriate primers, digested
with Sfi1 and cloned in pLNHX IR-EY vector, renamed as pLNHX IR-EY PC, similarly NC
was cloned in pLNHX IR-EY vector and renamed as pLNHX IR-EY NC.
2.8  LXXLL motif peptides
2.8.1 Short LXXLL peptide with random amino acid residues
Transcriptional activation by nuclear receptors is achieved by the recruitment of
coactivator proteins upon ligand binding. This recruitment involves an activation domain on
the receptor surface and an LXXLL motif located with in the comodulator (McInerney et al.,
1998;  Hall et al., 2000).
 LXXLL peptides with random residues are in the format M X7LX2LLX7 Ter, L is leucine and
X is any amino acid 
Oligonucleotides used
5´gatcggccactcaggccatgnnknnknnknnknnknnknnkctgnnknnkctgctgnnknnknnkn
nknnknnknnktaagtacaggcctgctaggccggatc 3´
5´gatccggcctagcaggcc 3´
(In nnk, n is any base, k is either g or t. Use of k at third position reduces the
frequency of stop codons, while preserving the diversity of amino acids. It ensures occurrence
of only one stop codon (uag).
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Elongation reaction was carried out in a reaction mixture of 50µL containing 50
pmoles from each oligonucleotides, 1µL Taq polymerase (5U/µL), 1µL dNTP mix (10mM
each), 5µL PCR buffer in an automated thermocycler using the following programme 
950C 5 minutes
450C 55minutes 
Hold 40C
Reaction product was purified by PCR purification kit, digested with Sfi1 and cloned
in pIRES-EYFP vector at Sfi1 restriction enzyme site.
Four pIRES-EYFP vector constructs with this random sequence are pIRES-EYFP LX1
(pLX1), pIRES-EYFP LX2 (pLX2), pIRES-EYFP LX3 (pLX3) and pIRES-EYFP LX4
(pLX4). Vector were sequenced by Jena Biosciences GmbH (Germany)
Amino acid sequence of peptide LX1  MLGFFYDLLWFLLCVCVLHP
Amino acid sequence of peptide LX2 MTIAVVFRLMCLLVLGGRVS
Amino acid sequence of peptide LX3 MLQTYVVFLEPLLFDFSRDR
Amino acid sequence of peptide LX4 MRVSLLSLLLRLLQSIAVYR
2.8.2 LXXLL peptides with varying number of motifs
Three short LXXLL peptides varying in number of LXXLL motif and amino acid
residues around the motif were chosen, named as LX 5, LX 6 and LX 7.
Peptide (LX 5) has one LXXLL motif with no additional amino residues on N and C
termini of it.
Peptide (LX 6) has two LXXLL motifs separated with three amino acid residues. 
Peptide (LX 7) has one LXXLL motif with two additional amino acid residues on C
termini of motif.
Amino acid sequence of peptide LX5      MLHRLL Ter
Amino acid sequence of peptide LX6  MLHRLLAAALSRLL Ter
Amino acid sequence of peptide LX7  MHLRLLQL Ter
Oligonucleotides used for LX 5
5´ aggccatgttacatcgtctactgtaaggcctgct 3 ´
5´aggccttacagtagacgatgtaacatggcctgag 3´
Oligonucleotides used for LX 6
5´aggccatgttacaccgtctccttgctgccgcactaagtcgcctcctataaggcctgct 3´
5´aggccttataggaggcgacttagtgcggcagcaaggagacggtgtaacatggcctgag 3´
Oligonucleotides used for LX 7
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5´aggccatgttacaccgtctccttcagttataaggcctgct 3´
5´aggccttataactgaaggagacggtgtaacatggcctgag 3´
Oligonucleotides for LX 5, LX 6 and LX7 were cloned in pIRES-EYFP vector at Sfi1
restriction site, vector was renamed as pIRES-EYFP LX 5 (pLX 5), pIRES-EYFP LX 6 (pLX
6) and pIRES-EYFP LX 7 (pLX7) respectively.
Vitamin D response element (VDRE) sequence
Oligonucleotides coding for one copy of VDRE sequence was cloned in the multiple
cloning site of pTAL-SEAP vector employing Xba1 restriction sites. Vector was renamed as
pTVE.
2.9 General cell culture technique
All cell lines were grown in a humidified 95% air, 5% CO2 (Heraeus) at 370C
routinely assayed for contamination. Before plating cells were counted by Coulter Counter.
Cells were cultured in Dulbecco´s modified Eagle’s medium (DMEM) supplemented with
2mM L-glutamine, 1.0mM sodium pyruvate and 10 % fetal calf serum /FCS).
2.9.1 Transfection with effectene reagent
Ecopack TM -293, NIH3T3 and HeLa cells were transfected transiently at about 75 %
confluence using Effectene transfection reagent (Qiagen). Cells were seeded 24h before
transfection. The following protocol as per the recommendation of manufacturer was
followed
Culture format   DNA (µg)     Enhancer      Buffer          Effectene        
     (µL)             EC (µL)          reagent (µL) 
24 well plate  0.3       2       75  5
12 well plate  0.4       3    100  6
6 well plate  0.6       5     150  9
60mm dish  1.5     12      200 15
*Note: In addition to this protocol some times concentration of reagents and DNA
were changed.
Co-transfection of HeLa cells with two vectors was carried out, by using Effectene
transfection reagent.
2.9.3 Transfection by lipofectamine
HeLa cells were transiently transfected using lipofectamine (Gibco/BRL) essentially
as described (Daub et al., 1997). For transfection in 6-well plates 1.0mL of serum free
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medium containing 7µL of lipofectamine and 1.0µg of plasmid DNA per well was used. After
4h, transfection mixture was removed and fresh medium was added.
2.10     Retrovirus
2.10.1 Retrovirus production
Ecopack TM-293 packaging cell lines (2x105 cells) were seeded in 6 well plates
coated with collagen1 one day prior to transfection. Retroviral vector constructs were
transfected by Effectene Transfection reagent according to the manufacturer’s protocol.
25µM/mL chloroquine was added to cells 3h before transfection. Post 24h of transfection,
medium was replaced with fresh medium lacking chloroquine. Forty eight hours later,
conditioned medium from these cells was harvested, filtered through 0.45µm sterile cellulose
acetate free filters The estimated titer of the retrovirus were 1-2 x 106 colony forming unit
/mL based on the G418 resistant colony formation of the NIH3T3 cells.
2.10.2  Retroviral infection 
NIH3T3TrkA-Ros cells (4x105 cells) were seeded in 60mm dishes one day prior to
infection. Conditioned medium from Ecopack TM 293 packaging cell line was harvested after
forty eight hours, filtered through 0.45µm sterile cellulose acetate free filters and added to
NIH3T3TrkA Ros cells. Cells were grown in presence of 8µg/mL polybrene for 24h. After
24h of infection medium was changed with fresh medium with out polybrene. Infected cells
were analyzed as indicated.
2.11 Cell proliferation
Cell numbers were counted by using a Coulter Counter. Medium was removed
followed by washing of cells with PBS. After washing with PBS, trypsin was added to cells to
detach them from the surface. Cell numbers are displayed per mL.
2.12 Fluorescence activated cell sorting (FACS) analysis
Flow cytometry allows counting and analysis of physical and molecular attributes of
particles in a liquid media. One of the most used applications is the analysis of cells and cell
(sub) populations on single cell level with probes like (antibodies, receptors, fluorescent
markers, streptavidin, etc). 
Infected cells were harvested by trypsinization after 48h and were resuspended at a
concentration of 106cells/mL in DMEM containing 10% fetal bovine serum. Samples were
analyzed by FACS by using an argon laser to excite cells at 488nm and a 530 ± 15nm band
pass filter to detect fluorescent emission. For FACS scans, 10,000 cells were typically
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analyzed by using a FACScan flow cytometer (Becton Dickinson). FACS data were analyzed
using CellQuest software.
2.13 Secreted alkaline phosphatase (SEAP) chemiluminescence detection 
SEAP detection was done by using Great EscAPe TM chemiluminescence detection kit
(Becton Dickinson) following manufacturer’s protocol. SEAP is a modified and heat resistant
alkaline phosphatase secreted directly in the medium. SEAP detection was generally done
after 24h of transfection of SEAP vectors using the following procedure. 110µL of cell
culture medium was taken from the transfected cells, centrifuged at 12,000rpm for 30
seconds, and supernatant was taken in fresh micro centrifuge tube.
SEAP assay protocol (For 96 well plate format)
Pipette 15µl of supernatant to each well, add 45µL of 1x dilution buffer. Incubate at
650C for 30minutes in a water bath, cool samples on ice for 2-3 minutes. Add 60µL of Assay
buffer to each sample; incubate for 5 minutes at room temperature (RT). Add 60µL of
1.25mM CSPD substrate diluted with chemiluminescent enhancer. Incubate for 30 minutes at
RT. Detection was carried out by luminometer (BMG, Germany).
2.14 Protein antibody array
2.14.1 Lysis of cells
Medium was removed from the treated cells and washed with PBS. Cells were
incubated in lysis buffer, scrapped off the plate and transferred into an eppendorf tube. Lysate
was vortexed, centrifuged at 13000rpm at 40C for 20-25 minutes.
2.14.2 Determination of protein concentration
Protein concentration was determined according to Bradford, 1976 method.
2.14.3 Protein detection by array tube 
Array tubes were purchased from Clondiag chip technologies (Germany). Array tube
contains 19 antibodies; each antibody is spotted three times. The same antibodies diluted in
1:5 ratios are also spotted three times. In addition to this, array tube contains markers and
controls. Proteins were spotted on the array tube following this protocol.
1.  Biotinylation of proteins
50µg of protein was mixed with 0.5µL (100µg/µL) of Biotin in a reaction mixture of
50µL (volume was make up with PBS) Incubated at 300C in a thermo-mixer with mild
shaking 500rpm for one hour.
2. Array Tube Blocking 
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250µL of 5% PBS-Milk powder was added to each array tube and incubated for 1h at
300C with shaking.
3. Array tube incubation with biotinylated protein.
Wash array tube with PBS, mix 50µg biotinylated protein from first step with 50µL
2% PBS-BSA and add to array tube. Incubate at 300C for 2h with constant shaking.
4. Washing 
Wash array tube with PBS-T (Tween 0.05%) two times for 5 minutes each at 800 rpm.
5. Array tube incubation with streptavidin gold
0.5µL of streptavidin gold in 99µL PBS-T was added to array tube and incubated at
300C for half an hour and washed thrice with PBS-T.
6. Detection
50µL from Silver enhancing kit A and B were mixed and added to Array tube and the
tube was put in the array tube reader (Clondiag) for detection.
Array data was analyzed by IconoClust software (Clondiag).
 
2.15 Random peptide library construction
Random library of 1x 106 peptides were synthesized employing pOS IRESGFP (gifted
by Klingmuller) bi-cistronic retroviral vector. In order to make random peptide library nnk
codons, where n denotes all four nucleotides and k denotes g and t were chosen for generation
of randomized codons. This ensures a more equal distribution of the amino acids in the library
and two out of three stop codons are omitted. Each peptide has 13 random amino acids. Two
partly complementary oligonucleotide sequences coding for 13 random amino acid residues
with restriction sites for Not1 and BamH1 at 5´and 3´ends respectively are;
5´ataagaatgcggccgctaaactatatgnnknnknnknnknnknnknnknnknnknnknnknnknnktaaggaattcgccg
gatccgcg 3`
(In nnk, n is any base, k is either g or t. Use of k at third position reduces the
frequency of stop codons, while preserving the diversity of amino acids. It ensures occurrence
of only one stop codon (uag).
Second oligonucleotide sequence 5´cgcggatccgcggaattcctta 3´ 
Annealing and elongation was carried out in a reaction mixture of 50µL containing 50
pmoles from each oligonucleotides, 1µL Taq polymerase (5U/µL), 1µL dNTP mix (10mM
each), 5µL PCR buffer in an automated thermocycler using the following programme 
950C 5 minutes
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450C 55 minutes 
Hold 40C
Reaction product was purified by phenol chloroform precipitation, digested with
BamH1 and Not1 and cloned in pOS IRESGFP retroviral vector.
Hundreds of transformations were carried out as described above. Colonies from agar
plates were scrapped by adding 2-3mL of LB medium to each plate. Colonies were scrapped
from plates (approximately 106 colonies) mixed, centrifuged, DNA was extracted and
subsequently purified by Qiagen kit.
DNA was transfected in packaging cell line, viruses were collected after 48h of
transfection. Target cells, were infected by viruses as described above.
2.15.1 Peptide rescue by PCR
Infected cells after treatment and sorting were allowed to grow in 96 well plate.
Peptides, which provided resistance to the cells against dexamethasone, were obtained by
using specific PCR primers to amplify them from isolated DNA. Cells after trypsinization and
washing were incubated in digestion buffer overnight at 50oC with mild shaking and DNA
was precipitated with repeated phenol chloroform extraction.
PCR was carried out by using the primers with restriction enzyme sites for Not1 and
BamH1. PCR product was purified, digested with Not1 and BamH1 for further recloning in
pOS IRESGFP retroviral vector.
Primer used 
Forward primer 5´ataagaatgcggccgctaaac 3´
Reverse primer 5´ ctggcggccgttactagt 3´
Vectors with recloned peptide were further used to infect cells in order to check if the
observed resistivity was due to the peptide or not.
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Results 
3.1 Targeting protein-protein interaction by expressing short domain specific peptide
Proteins interact with their cognate partners to carry out different functions necessary
for the growth and development of cell. Interactions are usually mediated by defined domains
that recognize specific interaction partners. There can be complementary interaction domains
of other proteins, nucleic acids or other molecular ligands. Domains can be highly specific for
one potential interaction or may have the specificity to interact with various ligands
permitting different interactions. In many cases proteins comprise more than one interaction
domains, providing the potential to form multi-protein complexes. Domains through their
interactions mediate the targeting of proteins to a specific sub-cellular location, nucleate the
formation of multiprotein signaling complexes, control the conformation, activity and
substrate specificity of enzymes. Studying protein interactions at the domain level gives a
global view of the complexity of the protein interaction network and possibly of protein
functions. Dissecting a particular signaling pathway by interrupting interaction between
different proteins can reveal specific informations and their effect on the cell. Interaction
between proteins can be disrupted by many ways like blocking interface of the partners,
mutating a specific region, or by organic molecules. Interfering protein interactions by
peptides as inhibitors is also a method of choice. However, instead of adding peptides directly
to cells,  peptides expressed within the cells to alter protein interactions could be a approach
to regulate cellular processes. In the present study a strategy based on disruption of specific
protein-protein interaction by expression of peptides that mimic protein binding domains was
implemented. One way to accomplish this approach is, to select peptide sequences from one
interacting partner where its cognate partner binds and express them in vivo.
For a cell to grow, proliferate and differentiate a number of processes involving
different protein-protein interactions are involved to carry out these functions. However, in
addition to protein interactions that enhance cell growth and differentiation, there are some
inhibitory protein interactions that limit proliferation and growth of cell. One such known
protein interaction inhibiting cell growth and differentiation occurs between tyrosine kinase
Ros and protein tyrosine phosphatase SHP-1 (PTP SHP-1). PTP SHP-1 interacts with tyrosine
kinase Ros at specific phosphorylated tyrosine residue and its dephosphorylation results in
inhibition of cell growth. This particular interaction was chosen as a target to interrupt it by
specific peptides derived from Ros tyrosine phosphorylation domain.
To target a known protein-protein interaction by peptides, an efficient tool is required
to express peptides and monitor them in vivo. To start with, a retroviral expression vector
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system was developed to express efficiently small specific peptides. pLNHX retroviral vector
(Clontech) was employed for this purpose. It was extensively modified by cloning Internal
Ribosomal Entry Site (IRES), Enhanced Yellow Fluorescent Protein (EYFP). hsp promoter
was replaced by human cytomegalovirus (CMV) major immediate early promoter. Multiple
cloning site was further modified to introduce restriction sites for two Sfi1 enzyme with
different overhangs to make sure unidirectional cloning of oligonucleotides encoding for
peptides, as a single cassette. Oligonucleotides were cloned in pLNHX vector at Sfi1
restriction sites. EYFP was used as a reporter and the presence of IRES makes sure that
peptides and EYFP are translated from the same mRNA transcript.
To study a possible interference of a known protein interaction by peptides specially
genetically modified cell line was used.  For interrupting tyrosine kinase Ros and PTP SHP-1
interaction, domain specific peptides were expressed in modified NIH3T3 cell line referred as
NIH3T3TrkA Ros cell line (gifted by F. Böhmer). These cells were expressing tyrosine kinase
Ros and PTP SHP-1. However, expression of PTP SHP-1 was anhydrotetracycline (atc)
regulated. 
3.1.1 Ros tyrosine phosphorylation domain specific peptides
To influence interaction between Ros tyrosine kinase and PTP SHP-1 short specific
peptides were selected from Ros tyrosine phosphorylation domain. Two peptide sequences
were derived from Ros tyrosine phosphorylation domain named as Positive peptide (Pos) and
Negative peptide (Neg). Pos has 13 amino acids identical to sequence of Ros tyrosine
phosphorylation domain with specific tyrosine residue necessary for PTP SHP-1 interaction.
Amino acid sequence of Pos is as;  MEGLNYMVLATKSSTer. Neg is identical to Pos except
tyrosine residue is replaced by phenylalanine. It thus, lacks the phosphorylation site to interact
with PTP SHP-1. Amino acid sequence for Neg is as; MEGLNFMVLATKSSTer.
Additionally, Pos and Neg were modified by adding self annealing flanking amino acid
sequence (GEFLIVIKSG) on both N and C termini. (Pos and Neg with self annealing flanking
amino acid sequence were designated as PC and NC respectively). Flanking sequence is
reported to protect peptides from protease degradation and provides a loop like structure to
the expressed peptide (Gururaja et al., 2000). In addition to these peptides one more peptide,
referred as Non specific peptide (NSP) having no resemblance with the Ros tyrosine
phosphorylation domain derived peptides and lacking tyrosine residue was used as a negative
control. Peptides were expressed from pLNHX retroviral vector as a part of a bi-cistronic
mRNA coding for the peptides and EYFP, both are translated  from same mRNA transcript
due to the presence of IRES. 
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Effect on NIH3T3TrkA Ros cell growth by short domain specific peptides
Fig 1; NIH3T3 TrkA Ros cells were infected with viruses from different pLNHX retroviral
vector constructs separately. Viruses were collected, filtered after 48h of transfection of Ecopack TM 293
packaging cell line. NIH3T3 TrkARos cells were analyzed to determine percentage of cells with the
respective peptide after 48h and 96h of viral infection. A significant increase in the number of cells
expressing Pos was found compared to cells expressing other peptides, which significantly increased after
96 h of infection. NIH3T3 TrkA cells were grown in absence of anhydrotetracycline (atc) throughout the
whole study indicating expression of SHP-1PTP.
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Fig 2; NIH3T3TrkARos cells after being infected with viruses from various retroviral vector
constructs separately and grown in absence of atc, were divided after 96h of infection. One group of
infected cells were treated with NGF (100ng/mL) for 6 days, while one was  grown in absence of
NGF as control. Medium with NGF was changed after every two days. Cells were analyzed to
determine the number of cells with respective peptide after 6 days of NGF treatment, a relatively
small increase in the number of cells expressing Pos was observed.
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3.1.2 Effect on NIH3T3TrkA Ros cell growth in absence and presence of PTP SHP-1
NIH3T3TrkARos cells were infected with retroviral vectors expressing different
peptides. Cells grown in absence of atc (expressing PTP SHP-1), were analyzed by FACS
after 48h and 96h of infection (transduction). As shown in Fig.1 a steep increase in percentage
of  cells expressing Pos in comparison to cells expressing other peptides was observed.
Surprisingly, cells expressing  PC (which is similar to Pos except the self annealing flank)
showed less proliferation enhancement than Pos expressing cells. Increase in Pos expressing
cells, suggest that the expressed peptide might be able to interfere between tyrosine kinase
Ros domain and PTP SHP-1 interaction. As Pos sequence has been derived from Ros tyrosine
phosphorylation domain it may act as an alternate binding partner for PTP SHP-1 to alter its
interaction with Ros tyrosine kinase. Since the peptide and EYFP are translated from the same
mRNA transcript increase in number of fluorescent Pos expressing cells directly indicates
enhancement in proliferation of cells (Fig 1a). Less proliferative effect observed in PC
expressing cells suggests that the peptide is not able to alter the said interaction. Although, PC
is similar to Pos except the self annealing flank. PC was expected to enhance more cell
proliferation than Pos due to the presence of self annealing clamp sequence that is reported to
enhance stability and providing a scaffold like structure to the expressed peptide. The reduced
effect of PC may be due to the decrease in flexibility of the peptide as the clamp gives a loop
like structure to the expressed peptide making it more structurally constrained and thus
possibly less effective for interaction. The loop might also have influence on the frame of the
peptide. Neg and NC proved less effective in enhancing cell proliferation as expected due to
lack of tyrosine residue in both peptides. Substitution of tyrosine amino acid with
phenylalanine devoids the peptide to be an interacting partner for PTP SHP-1. Besides that,
NC had clamp sequence which reduces its flexibility. This is consistent with the results as
cells expressing Neg and NC did not show increase in proliferation of cells. This may be
explained on the basis that these peptides were no longer able to disrupt interaction PTP SHP-
1 with tyrosine kinase Ros due to the lack of specific tyrosine residue. Furthermore,
expression of a non specific peptide (NSP) with no resemblance to Ros tyrosine
phosphorylation domain derived peptides showed no effect on cell proliferation enhancement
indicating NSP was unable to interfere the interaction. These results strengthens that Pos
expression did play a role in observed cell proliferation enhancement. When cells were grown
in presence of atc (no expression of PTP SHP-1) (Fig 3) a slight increase in cell proliferation
was observed in Pos expressing cells compared to other cells. This enhancement in cell
proliferation seen in Pos expressing cells was comparatively lower than cells grown in the 
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Effect on NIH3T3TrkA Ros cell growth by short domain specific peptides
Fig 3; NIH3T3TrkA Ros cells grown in presence of atc were infected with viruses from different
pLNHX retroviral vector constructs. Infected cells were analyzed after 48h and 96h of infection to determine
the peptide expressing cells. Percentage of Pos expressing cells were found higher than other peptide
expressing cells after 48h of infection and a steep increase in Pos expressing cells was observed after 96 of
infection compared to other peptide expressing cells. Data is mean of three separate experiments.
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absence of atc, suggesting that in addition to tyrosine kinase Ros and PTP SHP-1 interaction
some other  factors may also be  contributing  to the enhanced observed effect.
3.1.2 Stimulation of TrkA Ros by NGF  is not  influenced by peptides 
Modified cells were challenged with NGF (100ng/mL) post 96h of infection to
stimulate TrkA Ros receptor. This stimulation had relatively small effect on enhancement in
cell proliferation of peptide expressing cells. Increase in number of Pos expressing cells was
relatively higher when cells were grown in presence (Fig 4) or in absence of atc (Fig 2) than
other peptides. No strong effect on cell proliferation in peptide expressing peptides was
observed, indicating NGF did not play any major role in enhancing the effect of peptides.
Proliferation assay by counting cells by coulter counter was further done to study the effect on
cell proliferation. As seen in Fig 5 and Fig 6 when cells were grown in presence (Fig 5) and
absence (Fig 6) of NGF an overall relative increase in cell proliferation was seen. However,
slightly enhanced proliferation of Pos expressing cells reconfirmed a possible role of Pos in
depicting this enhanced proliferative effect. 
Ros tyrosine phosphorylation domain derived peptides were also expressed in normal
NIH3T3 cells (Fig 7). In these cells peptides did not induce proliferation and there is no
difference in activity between the peptides. Surprisingly, a decrease in PC and NC expressing
cells was observed after 48h of infection. These effects clearly indicate that the proliferation
seen in NIH3T3TrkA Ros cells is due to the domain specific expressed peptides and is
dependent on the expression of the intracellular part of the Ros receptor tyrosine kinase
domain from which they were derived. The observed effects clearly showed that the peptides
might be able to target specific interactions and could be used to influence a known protein
interaction. However, in the present study the enhanced proliferation is not dependent solely
on the disruption of Ros tyrosine kinase and PTP SHP-1 interaction. 
These results gave us a clue that peptides could be used to interfere a known protein
interaction. Based on this method of expressing peptides using efficient expression vector
system, peptides derived from specific motifs were used to target interaction between  nuclear
receptors and coactivators.
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Fig (1a); FACS analysis of NIH3T3TrkA Ros cells infected with viruses from different pLNHX
retroviral vectors (a) sorted cells after 48h (b) after 96h of infection. An increase in number of cells can be
observed in Pos expressing cells compared to other cells. This enhancement in number of cells reflects
increased proliferation in Pos expressing cells due to the peptide. Each experiment was repeated three
times.
Note: only sorted cells are shown
                in each picture
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Fig 5; NIH3T3TrkA Ros cells grown in presence of atc, were infected with viruses from
different pLNHX retroviral vectors separately. Cells were treated with NGF (100ng/mL) for 6 days
before being counted by Coulter counter. One group of virally infected cells was grown in parallel with
out NGF. Cell numbers indicate a relatively slight increase in number of  NGF treated  cells compared
to untreated cells. Cell numbers are mean of three separate assays.
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pLNHX retroviral vectors separately. Cells were treated with NGF (100ng/mL) for 6 days before being
counted by Coulter counter. One group of virally infected cells was grown in parallel with out NGF.
Coulter counter counting of cells indicated an increase in number of  NGF treated cells as compared to
untreated cells . Cell numbers are mean of three separate assays.
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Picture 1;
A Schematic outline of the modified NIH3T3TrkA-Ros cell line highlighting a
possible way of the peptides interfering with the tyrosine kinase Ros and SHP-1PTP
interaction after their expression in the cells.
Effect on  NIH3T3 cell growth by short domain specific peptides
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Fig 7; Normal NIH3T3 cells were infected with viruses from different pLNHX retroviral constructs
after 24h of plating. Post 48h and 96h of infection cells were analyzed to determine the peptide expressing
cells. Cells expressing different peptides did not show any increase in number of cells as seen in
NIH3T3TrkA Ros cells, which were modified to study the interaction of peptides with the intended
interaction of  tyrosine kinase Ros and SHP-1PTP. Since, no effect on NIH3T3 cells was observed it signifies
the role of domain specific peptides in enhancing proliferation in NIH3T3TrkA Ros cells. Data is mean of
three different experiments
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3.2 Nuclear receptor coactivator interaction specificity; Effect of short peptides with
LXXLL motif on transcription activation
Receptors as transcription factors play an important role in growth, development and
disease progression. Receptors are usually present on membranes, cytoplasm and in the
nucleus. Binding of ligand to receptor initiates a cascade of signal reactions leading to
expression of different genes. Ligands for membrane bound receptors bind directly to them
while ligands for nuclear and cytoplasmic receptors had to enter inside the cell to bind their
respective receptors. Once a ligand bound to a nuclear receptor it may form a heterodimer or
homodimer before binding to hormone response elements (HREs) present on DNA to initiate 
transcription. Various coactivators are recruited by receptors to enhance transcription.
Coactivators are reported to interact with the AF-2 region of the receptor via specific LXXLL
motifs whose consensus sequence and number varies from coactivator to coactivator. In the
present study, attempts were carried out to express different LXXLL peptides varying in
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Vitamin D induced transcription antagonized by short LXXLL peptides
expressed in vivo
Fig 8; HeLa cells were co-transfected separately with LXXLL peptide expressing vectors and a
SEAP reporter vector, which in addition to SEAP reporter gene has Vitamin D response element (VDRE)
sequence. Cells were treated with 10-6M vitamin D (Vit. D) post 24 hr of transfection. To determine
SEAP activity samples were taken 24h post Vit.D treatment. Vit. D induced expression of reporter gene
was significantly suppressed by flanked LXXLL peptides than non flanked peptides indicating their role
to antagonize the induced transcription as clear from the SEAP activities. Peptide LX4 showed relatively
higher effect in comparison to other flanked LXXLL peptides, while among non flanked ones peptide
LX7 has significant effect. Activities are the mean of triplicate assays
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number of LXXLL motifs and amino acid residues on N and C termini of the motif, with this
aim if they will be able to block receptor and coactivator interaction. Various LXXLL
peptides were chosen. In LX1, LX2, LX3 and LX4 pattern of motif and amino acids is as
X7LX2LLX7 where X is any amino acid and L is Leucine. Peptides with random LXXLL
motif and flanking residues around it avoid biasness to any specific amino acid in the
expressed peptide. Peptide LX5 contains only one motif (LHRLL) with out any additional
amino acid residue around the motif, peptide LX6 has two LXXLL motifs (LHRLL)
separated by three amino acid residues and finally peptide LX7 has one motif (LHRLL) with
two amino acid on C terminus of motif. In peptides LX5, LX6 and LX7 sequence of the motif
is LHRLL. It was chosen after comparing motif sequences from various coactivators and this
motif sequence was present in most coactivators that led to its selection. Cells were co-
transfected with Peptide-EYFP expressing and SEAP reporter expressing vectors. Each SEAP
vectors have varying number of different hormone response element copies. Enhanced yellow
fluorescent protein was used to monitor transfection efficiencies. 
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          Effect of LXXLL peptides on 9 cis-retinoic acid induced transcription
Fig 9; HeLa cells were co-transfected separately with LXXLL peptide expressing vectors and SEAP
vector, which in addition to SEAP reporter gene has Vitamin D response element (VDRE) sequence. Cells were
treated with 10-6 M  9-cis retinoic acid post 24 hr of transfection. To determine SEAP activity samples were taken
after 24 h of 9-cis retinoic acid treatment. Cells expressing LXXLL peptides with flanking sequences (LX1-LX4)
indicated less SEAP activity signifying the role of peptides in inhibiting the reporter gene expression by acting as
antagonists. Non flanked LXXLL peptides were less effective in suppressing the induced effect. Activities are
mean of three separate experiments.
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All peptides were expressed in two cell lines; HeLa and NIH3T3 by employing bi-cistronic
vector expressing EYFP and peptide from the same mRNA transcript. Various drugs like
Vitamin D, 9 cis-retinoic acid, Dexamethasone and Forskolin were used separately as
inducing agents to study the antagonizing effect of peptides on induced transcription. 
3.2.1 Suppression of vitamin D and 9-cis retinoic acid induced transcription.
HeLa cells were co-transfected with Peptide-EYFP expressing vector along with
SEAP reporter vector having Vitamin D response element (VDRE) sequence. Post 24h of
transfection cells were treated with 10-6M vitamin D (Vit.D)  for 24 h. As seen in (Fig 8) Vit.
D strongly induced OC promoter driven SEAP reporter gene. With the expression of peptides
induced activation got decreased as indicated by the SEAP reporter activity. This decrease
may suggest that the peptides have ability to block vitamin D receptor (VDR) and coactivator
interaction. 
Hall et al., 2000 reported LXXLL peptides interact directly with the AF-2 domain of the
nuclear receptor family indicating blockade of this region may prevent transcriptional
activation by receptor and supports the prevalent idea that the receptor must recruit an
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Efficiency of peptide mediated suppression is concentration dependent
Fig 10; HeLa cells were co-transfected separately with increasing concentration (100ng, 200ng,
400ng and 800ng) of LXXLL peptide expressing vectors as indicated and SEAP vector  having Vitamin
D response element (VDRE) sequence. Cells were treated with 10-6 M  Vit D post 24 hr of transfection.
SEAP activity was determined  after 24 h of Vit D treatment. Vit D induced  SEAP gene expression  as
indicated by SEAP activity.  With increase in concentration of peptides SEAP activity showed gradual
decrease indicating that with increase in peptide expressing vectors more  copies of peptide may be
available to antagonize the  induced effect . Activities are mean of three separate experiments.
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additional factor(s) through this site to manifest function. Coactivator recruitment is necessary
for receptor to carry out transcriptional activation and they interact with ligand bound receptor
via LXXLL motif.
 Expressed LXXLL peptides in HeLa cells treated with Vit. D showed different extent
of antagonizing effect as seen in (Fig 8). With flanked peptides being more potent than non
flanked peptides as indicated by SEAP activities, each SEAP activity reported is mean of
three separate experiments. Peptides lacking additional sequences were quite
ineffective except LX7 which exhibited better suppressive effect than LX5 and LX6. One
possible reason for this may be that these peptides are not able to interact effectively with AF-
2 domain of receptor to block its interaction with the coactivator due to lack of additional
amino acid residues. Observed variation in activities of flanked LXXLL peptides among
themselves led  to the supposition that these peptides might differ in their affinities to interact 
Comparison of LXXLL peptides and non-LXXLL peptides on antagonizing
induced dexamethasone transcription
Fig 11;  HeLa cells were co-transfected separately with LXXLL peptide expressing vectors and SEAP
vector having three tandem copies of glucocorticoid response element (GRE) sequence in one group, while in
other group cells where cotransfected with non-LXXLL peptide expressing vectors and SEAP vector. Cells were
treated with 10-6 M  dexamethasone post 24 hr of transfection. SEAP activity was determined after 24h of
dexamethasone treatment. Dexamethasone treatment induces SEAP activation which was significantly lowered by
expression of peptides to different extent with peptides having long flanking sequences have preferentially better
antagonizing effect as indicated by decrese in activities than non flanking LXXLL peptides. Peptides lacking
LXXLL motif did not show any considerable effect on suppressing the induced effect which suggest that for a
peptide to be an active antagonist LXXLL motif sequence should be present in it.
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with ligand bound receptor. Among flanked peptides LX4 and LX1 showed better suppressive
effect in Vitamin D induced treatment than LX2 and LX3. 9-cis retinoic acid induced
activation (Fig 9) was also suppressed by peptides. The observed pattern of suppression was
similar as seen in Vit. D induced activation. However, 9-cis retinoic acid induced SEAP
reporter activities were significantly lower than Vit. D. This decrease in activity in case of
retinoid treatment may suggest that in VDR-RXR heterodimer, VDR interaction with the
coactivator and hormone response element play a significant role. 
3.2.2 Efficiency of peptide mediated suppression is concentration dependent
Antagonistic property of peptides was found to be dose dependent (Fig 10). With
increase in the concentration of peptide expressing vector a stronger suppressive effect on
induction was observed as indicated by decrease in SEAP activity in case of peptides with
flanking sequence (LX1-LX4). This indicates that with increase in concentration more copies
of peptide may be available to interact with the receptor complex to prevent coactivator
recruitment to influence the induced transactivation. 
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Forskolin induced effect antagonized by expressed peptides
Fig 12; HeLa cells were co-transfected separately with LXXLL peptide expressing vectors and
SEAP vector which contains three tandem copies of cAMP response element (CRE) sequences in addition
to SEAP reporter gene. Cells were treated with 10µM forskolin post 24 hr of transfection. SEAP activity
was determined after 24 h of forskolin. treatment. Forskolin  treatment  induces SEAP activation which was
significantly lowered by expression of peptides to different extent. LXXLL peptides with long flanking
sequences have preferentially better antagonizing effect than non flanking LXXLL peptides. Activities are
mean of three separate experiments.
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Table 1;
SRC1        YSQTSHK LVKLL TTTAEQQ NR1
NcoA1       YSQTSHK LVQLL TTTAEQG NR1
GRIP1       DSKGQTK LLQLL TTKSDQM NR1
SRC1    LTARHKI LHRLL QEGSPSD NR2
NcoA1       LTERHKI LHRLL QEGSPSD NR2
GRIP1       LKEKHKI LHQLL QDSSSPV NR2
SRC1    ESKDHQL LRYLL DKDEKDL NR3
NcoA1        ESKDHQL LRYLL DKDEKDL NR3
GRIP1       KKKENAL LRYLL DKDDTKD NR3
NcoA1       DQCISSQ LDELL CPPTTVE NR4
NcoA1       GVIEKES LGPLL LEALDGF NR5
SRC1    QAQQKSL LQQLL TE  stop NR4
NcoA1        QAQQKSL LQQLL TE  stop NR6
CBP    AASKHKQ LSELL RGGSGSS NR1
p300    AASKHKQ LSELL RGGSGSS NR1
CBP       RKLIQQQ LVLLL HAHKCQR NR2
p300       RKLIQQQ LVLLL HAHKCQR NR2
CBP       RSISPSA LQDLL RTLKSPS NR3
p300       GTVSQQA LQNLL          RTLRSPS NR3
RIP               DSIVLTY  LEGLL MHQAAGG NR1
140      GKQDSTL LASLL QSFSSRL NR2
          YGVASSH  LKTLL KKSKVKD NR3
           PSVACSQ  LALLL SSEAHLQ NR4
          DSIVLTY  LEGLL MHQAAGG NR5
           SHQKVTL  LQLLL GHKNEEN NR6
LX1          MTIAVVFR LMCLL VLGGRVR
LX2           MLGFFYDL LWFLL CVCVLHP
LX3          MLQTYVVF LEPLL FDFSRDR
LX4          MRVSLLSL LLRLL QSIAVYR
LX5     M LHRLL
LX6        M LHRLL AAA LSRLL
LX7  M LHRLL QL
Comparison of LXXLL motifs with amino acid residues around the motif from various coactivators
with expressed LXXLL peptides. Expressed peptides share varying number of amino acid residues with
coactivators, with peptide LX4 is sharing more number of flanking amino acid residue around LXXLL
motif than other peptide. Peptide LX7 shares amino acid Q with other coactivators sequences.
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3.2.3 Suppression of dexamethasone and  forskolin induced transcription
In order to further confirm role of peptides and their ability to interact and antagonize
the induced activation, SEAP vectors with GRE and CRE response elements were used to
study the effect of dexamethasone and forskolin on induced transactivation respectively.
Dexamethasone binds to glucocorticoid receptor and the receptor ligand complex binds to
glucocorticoid response element (GRE) and initiates transcription after coactivator
recruitment.
Treatment of pGRE-SEAP vector transfected cells with dexamethasone showed a
significant increase in SEAP activity as compared reporter activity of untreated transfected
cells. Increase in reporter activities indicated the induced effect of dexamethasone on GRE
mediated transcription of the reporter gene. On expressing LXXLL peptides a decrease in
SEAP activity (Fig 11) was observed in the same pattern as in Vit. D treatment with peptides
having flanking sequences being more antagonistic than non flanking ones. Forskolin induced
transcription was suppressed by peptides (Fig 12) as in dexamethasone, however peptides
vary in their pattern of efficiency.
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Fig 13; HeLa cells were co-transfected separately with LXXLL peptide expressing vectors and SEAP
vector which contains three tandem copies of cAMP response element (CRE) sequence in addition to SEAP
reporter gene. Cells were cross treated with dexamethasone post 24 hr of transfection. SEAP activity was
determined after 24 h of treatment. Forskolin induced SEAP reporter activity was stronger than cross treatment
with dexamethasone. SEAP activity was lowered by LXXLL expressed peptides indicating their role as
antagonists for activation. LX3, LX4 and LX7 seem to have better effect than other peptides. In cross treatment
reporter activities were comparatively less than normal treatment of drug. Activities are mean of three separate
experiments.
Cross treatment of pCRE-SEAP vector transfected cells with dexamethasone
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Dexamethasone mediated transcription of pCRE-SEAP reporter gene indicating a cross talk
between glucocorticoids and cAMP. Groul et al., 1993 have reported synergism between
glucocorticoids and cAMP. Dexamethasone induced CRE transcription was significantly
lower than induced by forskolin (Fig 13). Forskolin was also found to induce transcription of
GRE-SEAP reporter gene (Fig 14) indicating a possible cross talks of cAMP and
glucocorticoid receptor. Transcription of CRE/GRE SEAP reporter gene by dexamethasone
and forskolin respectively was subjected to study the effect of expressed LXXLL peptide to
suppress the induced transcription. Peptides were able to suppress the SEAP reporter activity
in both cases (Fig 13, 14) with flanking LXXLL peptides being more potent in antagonizing
the induced effect compared to non flanked ones. All these results elucidate a potential role
for short LXXLL peptides when expressed in vivo to act as antagonists to suppress the
induced transcription by different agents. 
3.2.4 Adjacent amino acids are major determinants of efficiency
 Flanking peptides exhibited variation in reducing the reporter activity that
corresponds to their ability to act as antagonistic agents. Among flanking peptides LX4 and in
non-flanking peptide LX7 seemed more effective than others. The significant antagonizing
effect of peptides with flanking sequences on both N and C termini indicated that presence of
amino acid residues around LXXLL play a significant role. On comparing the flanking
residues of these peptides with the residues around LXXLL residues in various coactivators
(Table 1), LX4 was found to share maximum number of amino acids around LXXLL motifs
with high affinity peptides present in various coactivators, followed by LX3, LX1 and LX2.
This suggests that residues around the motif may help the peptide in properly interacting with
AF-2 domain of activated receptor and block its interaction with the coactivators. However,
this blocking seems was also found to dependent on presence of particular amino acid residue
present around the motif, as can be argued on the basis of LX4 which shares not only the
position but sequence of amino acid residues with coactivators (Table 1). Among other
peptides with no or few amino acid residues around the motif peptide LX7 was found to be
exerting better effect than LX5 and LX6. On comparing LX7 with coactivators this effect was
attributed to the presence of amino acid glutamine (Q) present in the peptide which it shares
with high affinity peptides. Thus, even a single residue seems to be having a role in binding to
receptor ligand complex and effecting transactivation. Peptides with only one LXXLL motif
(LX5) interacted with receptor ligand complex to block recruitment of coactivator and thus
acted as antagonists of the induced activation as indicated by reporter gene activities observed
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for the first time. A comprehensive comparison of antagonistic effect of flanked peptide and
non flanked peptide is elaborated in Table 2.
Peptide with two close motifs (LX6) did not act as strong antagonist as thought due to the
presence of  two motifs. It was believed, if LXXLL motif alone is required for a peptide to act
as antagonist then on that basis LX6 should be more effective than other peptides. As per the
reporter activity LX6 (Table 2) is the least active peptide in down regulating the induced
effect indicating that not only the number of motif are necessary but their specific position is
also equally important as seen in most of the coactivators. Peptide LX5 that is devoid of any
additional residue resulted merely in suppressing the induced effect, emphasizing the need of
additional residues around the motif. To confirm whether the LXXLL peptides do really act as
antagonists three different non LXXLL peptides as described earlier Pos, Neg and PC were
expressed in combination with pGRE–SEAP vector and treated with dexamethasone. All
these peptides lack LXXLL motif, as clear from Fig 11 no significant suppression in induced
Table 2: Comparison of expressed LXXLL peptides on antagonizing  the induced
transcription by  different drugs.
Comparative analysis of different peptides on treating HeLa cells with vitamin D, retinoic acid,
dexamethasone, forskolin and cross treatment of dexamethasone and forskolin after co-transfecting cells with
LXXLL peptide expressing vectors and vectors with specific Hormone response elements (HREs) respectively.
Peptides with flanking amino acid residues around the LXXLL motif were found to be better in antagonizing the
induced transcription by various agents than peptides lacking flanking residues. Among flanked peptides LX4 was
having higher suppressive effect in different treatments followed by LX3 except in forskolin treatment where LX3
had better effect on forskolin than LX4. Effect  of peptides seems to be related with the number of flanking amino
acids a peptide shares with high affinity peptides which was higher in LX4 followed by LX3. Among the non
flanked ones LX7 showed better suppressive peptide than LX5 and LX6. LX7 shares amino acid `Q´ with many
high affinity peptide explains its role in being more potent than other non flanking peptide. On comparing drug
treatments, dexamethasone induced transcription was overall highly suppressed by peptides followed by vitamin D
and retinoic acid respectively.
No 
treatment Dex VitD RA Dex/cre Forskolin Fors/GRE
Control 
plasmid 100% 100% 100% 100% 100% 100% 100% 100%
pLX3 100% 34% 45% 45% 51% 45% 44% 44%
pLX4 100% 31% 38% 34% 40% 64% 55% 43%
pLX1 100% 35% 41% 44% 60% 58% 62% 50%
pLX2 100% 39% 46% 49% 69% 53% 70% 54%
pLX7 100% 63% 58% 69% 68% 80% 59% 66%
pLX6 100% 73% 75% 84% 91% 87% 81% 82%
pLX5 100% 77% 78% 73% 84% 94% 73% 80%
100% 50% 55% 57% 66% 68% 63%
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activity was observed by these peptides. Ineffectiveness of these peptides confirms role of
LXXLL peptides to act as signature motifs in coactivators to recognize and interact with
receptor.
3.2.5 Pattern of efficiency is different for nuclear receptor mediated transcription and
PKA (forskolin) mediated transcription
Forskolin induces the cAMP pathway by activating adenylate cyclase. cAMP leads to
the phosphorylation of CREB which binds to CRE and carries out transcription. Forskolin
mediated cAMP response element (CRE) dependent reporter gene expression was
significantly lowered by expression of the LXXLL peptides (Fig 12), indicating their role in
interacting with CREB complex and thus prevent the coactivator recruitment. Forskolin
strongly induced CRE mediated expression of reporter gene than by other agents. Influence of
flanked peptides was higher than non flanked ones as seen earlier in dexamethasone and
Vit. D treatment. However, change in pattern of peptide efficiency was observed in forskolin
treatment with peptide LX3 being more effective as compared to LX4 seen in case of
dexamethasone and Vit. D treatment. Although LX3 shares less number of residues with the
high affinity peptides present in various coactivators than LX4 peptide. Change in efficiency
Fig 14; HeLa cells were co-transfected separately with LXXLL peptide expressing vectors and
SEAP vector which contains three tandem copies of glucocorticoid response element (GRE) sequence in
addition to SEAP reporter gene. Cells were cross treated with 10µM forskolin post 24 hr of transfection.
SEAP activity was determined after 24 h of dexamethasone induced SEAP reporter activity was stronger than
cross treatment with forskolin. SEAP activity was lowered by LXXLL expressed peptides indicating their
role as antagonists for activation. LX1, LX4 and LX3 seem to have better effect than other peptides.
Activities are mean of three separate experiments.
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Cross treatment of pGRE-SEAP vector transfected cells with forskolin
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may be due to variation in function as PKA mediated phosphorylation of CREB and its
interaction with SRC-1 or other proteins occurs in cytoplasm rather than in nucleus. 
3.2.6 LXXLL peptides are active in different cell types 
Does the effect of expressed peptides on antagonizing the receptor mediated
transcription remains constant or varies in different cell type? It was found to remain same in
case of NIH3T3 and HeLa cell line. Treatment of NIH3T3 cells with Vit. D after being
transfected with VDRE-SEAP vector leads to significant increase in VDRE driven SEAP
activity (Fig15) compared to control. Peptides antagonized the Vit. D induced transcription in
same way as observed in HeLa cells with LX4 peptide being more effective followed by LX1,
LX3 and LX2 among peptides with flanked LXXLL motif, while LX7 was among non
flanking peptides. As observed in HeLa cells antagonistic property was dose dependent, same
dose dependency was observed in NIH3T3 cells (Fig 16). This emphasis that the role of the
peptides is not cell dependent. Similar results as in HeLa on treatment with dexamethasone
and Forskolin were observed in NIH3T3 cells (Fig 17). Further confirming role of peptides is
not depending on cell type and their ability to interact and suppressive the induced effect
remains same. 
            Vitamin D induced transcription antagonized by short LXXLL peptides expressed in vivo
( in NIH3T3 cells)
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Fig 15 : NIH3T3 cells were co-transfected separately with LXXLL peptide expressing vectors and
SEAP vector which contains in addition to SEAP reporter gene vitamin D response element (VDRE)
sequence. Cells were treated with 10-6 M Vit. D post 24 hr of transfection. For SEAP activity samples were
taken after 24 h of Vit D treatment. Lower SEAP activities were observed in case of cells expressing flanked
LXXLL peptides; less SEAP reporter induction indicated the role of peptides in antagonizing its expression.
Flanked peptides were better suppressing this effect than non flanked ones suggesting the possible role of
flanking amino acid residues
                                                                            Results                                                                                   53
3.2.7 Influence of LXXLL peptides on cell proliferation and signal transduction
Dexamethasone is a well known anti-proliferative agent which blocks cell cycle and
thus prevents cell growth. While studying the effect of LXXLL peptides on suppressing the
dexamethasone induced effect an increase in cell death was observed which was not observed
when cells were treated with Vit. D and forskolin. Cell proliferation assay (Fig 18) indicated
an increase in cell death in dexamethasone treated cells transfected with LX peptide
expressing vectors. Peptides with flanked sequences enhanced anti-proliferative effect more
than non flanked ones. To deeper understand this more, protein antibody array analysis was
done to determine the various proteins involved in different pathways. Data from array
indicated decrease in number of proteins involved in MAPK kinase pathway and increase in
some other proteins (Fig 19, 20). Most of the phospho proteins like Phoso Erk2, Erk 5, Erk 4,
were decreased. p38 which gets elevated in stress condition was found to be increased. An
increase in Phospho Stat3, NF-kß was also observed. Glucocorticoids decrease level of c-myc
which plays a role in cell progression, further decrease in its level was observed in cells
expressing flanked LXXLL peptides, in addition to it decrease in the akt level was also seen.
Increased cell death in presence of LXXLL peptides may be due to decrease in phospho
proteins especially that of MAP Kinase which play an important role in cell progression and
growth. Enhanced effect on cell death due to LXXLL  peptides was not observed in vit D and
retinoic acid  treatments  inferring no down regulation in phospho proteins  and other kinases.
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Antagonizing effect of expressed LXXLL peptides is concentration
dependent
Fig 16; NIH3T3 cells were co-transfected separately with increasing concentration (100ng, 200ng,
400ng and 800ng) of LXXLL peptide expressing vectors and SEAP vector, which in addition to SEAP
reporter gene has  Vitamin D response element (VDRE) sequence. Cells were treated with 10-6 M Vit D post
24h of transfection. SEAP activity was determined after 24h of Vit.D treatment. With increase in
concentration of LXXLL peptide expressing vector SEAP activity showed gradual decrease indicating higher
concentration of peptides results in more copies of peptide available to antagonize the Vit D effect. Both in
HeLa and NIH3T3 cells LX4 exhibited more antagonistic effect
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Glucocorticoid/ forskolin induced effect suppressed by expressed  LXXLL
peptides.
                                (A)                                                                                            (B)
Fig 17; (A) NIH3T3 cells were co-transfected separately with LXXLL peptide expressing
vectors and SEAP vector which contains three tandem copies of glucocorticoid response element (GRE)
sequence in addition to SEAP reporter gene. Cells were treated with 10-6M dexamethasone post 24h of
transfection
(B) LXXLL expressing vector were co-transfected with pCRE-SEAP vector in NIH3T3 cells
and treated with 10µM Forskolin post 24h of transfection. SEAP activity was determined after 24h of
treatment. Antagonizing effect of peptides with flanking sequences in NIH3T3 and HeLa cells showed
similar order of effectiveness as antagonizing effect of dexamethasone and forskolin.
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Cell proliferation of  LXXLL peptide expressing cells in presence of dexamethasone
Fig 18; Cell proliferation assay of HeLa cells transfected with various pLX peptide
expressing vectors. Post 24h of transfection cells were treated with dexamethasone (10-6M) for
24h, cells transfected with LX1 and LX4 expressing vectors showed more cell death on treatment
with dexamethasone than cell transfected with LX5, LX7 and vector alone.
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Antibody Array data of cells expressing LXXLL peptides grown in presence
of  dexamethasone
Fig 19; Protein antibody array data of HeLa cells transfected with different peptide
expressing vectors. Cells were treated with 10-6M dexamethasone for 24h post 24h of
transfection. 50µg of proteins were labelled on the Array Tube. A number of proteins were
found to be downregulated and few upregulated on dexamthasone treatment.
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(c)
(b)
(a)
Fig 20; Photomicrographs of Protein antibody array of HeLa cells treated with dexamethasone
after being transfected with LXXLL peptide expressing vectors. (a) Control (b) cells with vector pLX4
(c) cells with vector LX1. Protein extracts from transfected cells obtained after 48h of treatment were
analyzed by antibody array tubes. Each antibody is spotted three times in the tube. A number of  proteins
were found to down regulated in cells expressing LX peptides. While an up regulation in stress related
proteins was also found.
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3.3 Peptide expression library approach to search novel bio active peptide
Peptide library method offers a unique approach to the elucidation of protein
interaction networks and signaling pathways. Many enzymes that act on protein-kinases,
phosphatases, proteases, deacetylases and acetyltransferases to name a few recognize their
substrate on the basis of sequence context surrounding the site of modification. Likewise,
protein-protein interactions are often mediated by modular domains, including SH2, PTB,
SH3 and FHA domains that interact with short linear stretches of protein sequences, often in
the context of post-translational covalent modifications to the binding partner. Peptide
libraries offer a rapid means for the elucidation of recognition sequences for these proteins
and domains; in essence, a practical alternative to the laborious individual analysis of
impossibly large number of peptides or mutant proteins. Developments in bioinformatics
enable scanning of protein sequence database with complex databases derived from peptide
library studies, providing an avenue for the identification of candidate protein targets.
Peptide library approaches can be broadly grouped into methods employing either
synthetic or encoded libraries. Synthetic library methods include spatially addressable
positional scanning libraries (PSLs), mixture based oriented peptide libraries (OPLs) and one
bead one peptide solid-phase libraries. PSL and OPL approaches have the advantage of
allowing exhaustive analysis of the contribution to specificity of each amino acid at each
position within the library. Rather than analyzing individual peptides, however, these libraries
generate consensus motifs that have the drawback of masking interactions between positions
or the existence of multiple binding modes. Encoded libraries, phage display being by far
most popular (but also including mRNA display and interact cell expression based systems)
and immobilized split-pool synthetic libraries provide a collection of sequences that are
positively selected. Although these approaches allow identification of cooperativity between
binding subsites, the labor involved with sequencing a large number of clones or beads
generally means that weaker selections are overlooked and negative selections cannot be
inferred. 
Combinatorial peptide libraries have been playing a major role in the search for new
drugs, ligands, enzyme substrates, and other specifically interacting molecules, such libraries
are composed of millions of peptides. The principal features of these libraries require a
versatile repertoire, an easily identifiable tag for each of the library members, a simple
method of synthesis, and a compatibility with the biochemical milieu. Two types of
combinatorial libraries are in use: synthetic libraries and biological (mainly phage display)
ones. An advantage of the biological libraries is due to the ability of each of the library
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members to replicate it and to the fact that they carry their own coding sequences. In recent
years, there have been a growing number of examples of the successful isolation of peptide
ligands for enzymes from phage-displayed combinatorial peptide libraries. These peptides
typically bind at or near the active site of enzymes and can inhibit their activity, while the
peptide ligand isolated from phage-displayed libraries may not resemble the chemical
structure of the normal substrate of enzyme. Peptides can be used as an inhibitor to evaluate
the function of the enzyme or for drug discovery efforts (i.e., as a lead compound for
peptidomimetic design or as displaceable probe in high-throughput screens of libraries of
small molecules). Combinatorial peptide library approach has been applied in identification of
biologically active peptides.
3.3.1 Design and preparation of random peptide libraries
Combinatorial retroviral peptide library approach has been used to screen potential
peptides helping in elucidating various mechanisms a cell undergoes. Random peptide library
based on nnk codon system, where n denotes all four nucleotides and k denotes g and t was
synthesized to screen bioactive peptides. nnk coding system ensures a more equal distribution
of the amino acids in the library and two out of three stop codons are omitted. Peptide library
has vast diversity due to presence of large number of different peptides which makes it more
suitable medium to isolate a bioactive peptide. Peptide libraries are preferred to cDNA
libraries due to limited diversity of cDNA library. A random peptide library of 13 amino acids
based on pOS IRESGFP vector (pOS) was synthesized. For library synthesis two partly
complementary oligonucleotide sequences were used, one having bases for 13 random amino
acids and restriction site for Not1 and BamH1 on 5´ and 3` of random bases respectively.
Another, short oligonucleotide sequence complementary to first one was used for elongation
to make the complementary double stranded, followed by restriction digestion with Not1 and
BamH1. Digestion product after cloning in pOS was extensively used for transformation of
E.coli to get as many as 106 colonies. Each colony represents vector with different peptide of
13 amino acids. All colonies were scrapped and proceeded to get the vector DNA. Peptide
library has complexity of 106 peptides, theoretically a sufficient number to cover a vast
diversity. Peptide libraries have an advantage of comprising a number of different
combinations of amino acids thus enhancing chances of getting bioactive peptides.    
3.3.2 Identification of peptide conferring resistance to dexamethasone toxicity in
fibroblasts
Employing combinatorial peptide approach, an attempt was made to screen peptide
library to isolate peptides that could provide resistance to cells against anti-proliferative effect
of dexamethasone. Dexamethasone, a known antiproliferative agent blocks cell progression in
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different cell lines normally by causing an arrest in the G1-phase of the cell cycle. Random
peptide library of 13 amino acids based on pOS was designed with approximately 106 peptide
combinations, a satisfactory number to cover the theoretical diversity of the library with this
aim aim to get a peptide able to overcome the dexamethasone induced toxicity.
Retroviral vector approach was employed as it ensures presence of single peptide in a single
virus particle, which could be rescued and sequenced. Peptide library was transfected in Eco
Pack packaging cell line, viruses were collected after 48h and 72h of infection and used to
infect (transduce) target NIH3T3 cells. NIH3T3 cells post 72h of transduction were plated and
treated with dexamethasone (10-4M) for 48h. This concentration was chosen after comparing
the toxicity on cells by various concentrations (10-4M, 10-5M, and10-6M). 10-4M was found to
Scheme for the peptide library screen. To initiate a screen, a peptide library (complexity 1x 106)
encoded  within the vector was transfected into the retroviral packaging cell line Ecopack Tm 293. The viral
particles were collected and then used to transduce NIH3T3 cells. The infected cells were treated with a high
dose of dexamethasone. The peptide sequence were rescued from surviving and FACS sorted cells by PCR
from genomic DNA, isolated peptide was recloned in the vector to confirm the dexamethasone resistivity.
PEPTIDE IRES EYFP
Peptide library insert
NIH3T3 cells
Dexamethasone
Transduction
FACS Sorting
Infected
fluorescent cells
Dead cells
Sorted cells were allowed to grow, Genomic DNA
was extracted.
PCR was done to identify peptides from cells
resisting toxicity
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be more toxic and causes considerable cell death than other concentrations. On treatment of
normal cells with dexamethasone (10-4M) cells die drastically (Fig 23), while cells infected
with peptide library on treated with dexamethasone for 48h showed little resistance to
dexamethasone induced toxicity. Cells that resisted toxicity were sorted by FACS sorter and
allowed to grow in 96-well plate for few days. Genomic DNA was extracted from these cells.
PCR was carried out (Fig 22) using vector specific primers to get the specific peptides present
in the cells. Sequencing of PCR product resulted in identification of a peptide that could have
provided resistance to cells against dexamethasone. Amino acid sequence of the peptide
referred as (Dex Pep) was found is as MSRRHRGGLLSVDT. In order to be sure that the
peptide provided resistance to dexamethasone toxicity, peptide was recloned in pOS. NIH3T3
cells were transduced with this vector followed by dexamethasone treatment. As seen in (Fig
23) cells infected with screened peptide resisted dexamethasone induced cell death and an
enhancement in cell growth was observed compared to dexamethasone treated uninfected
cells. To further make sure that this resistive effect is by screened peptide, cells were infected
separately with normal pOS and with pOS having a non-specific peptide (a random peptide
having no effect on resisting dexamethasone inducing toxicity). Both have no effect on
resisting dexamethasone induced toxicity after analyzing cells post  24 and 48 h (Fig 23 and
24) of drug treatment. As seen from figures, with increase in time period of treatment extent
of cell death increases. No effect on suppressing induced toxicity by normal vector and vector
with non-specific peptide emphasizes the role of screened peptide in resisting toxicity of cells
and also indicates that this effect is not vector specific. Proliferation assay (Fig 21) of cells
further confirm the role of screened peptide in enhancing the cell growth of dexamethasone
treated cells. It overrides dexamethasone induced toxicity to some extent, if not completely.
The resistance to dexamethasone induced toxicity by the peptide raises the question whether
the peptide after expression is functioning within the cell or it is secreted outside the cell to
overcome the dexamethasone induced toxicity shown by the cells. Spent medium from the
cells infected with the screened peptide (Dex pep) was added to NIH3T3 cells followed by
dexamethasone treatment for 48h. Cells did not resisted dexamethasone induced cell death as
was seen in cells expressing the peptide (Dex pep), it may indicate that the peptide is not
secreted outside the cell. In case the peptide is secreted outside the cells resistance to the
dexamethasone induced cell death should have been observed by adding the spent medium
from the infected cells to normal NIH3T3 cells. Lack of resistivity effect on cell toxicity was
also observed in cells treated with spent medium from pOS infected cells and pOS IRESGFP
vector having non specific peptide. This led us to speculate that the peptide after expression
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remains within the cell after expression and functions somehow to overcome the induced
toxicity. The mechanism by which this peptide overcomes the dexamethasone toxicity and
induces resistance needs to be studied further. Retroviral peptide libraries were used also by
other groups (Matza-Porges et al.,2003; Xu et al.,2001) to search and isolate peptides that
influence cellular proliferation and lead to better survival of the cell. So far the targets through
which these peptides act have been identified only in a few cases (Xu et al.,2001; Tenson et
al.,1997).
 1         M          2
Fig 22; NIH3T3 cells infected with random peptide library, showing resistance to dexamethasone
toxicity were sorted by FACS sorter and allowed to grow. Genomic DNA extracted from these cells was used
to perform PCR using vector specific primers to isolate provirus sequence, providing resistance to induced
toxicity  were further recloned to check their response again. Lane 1 and 2 shows PCR products from the
extracted DNA using vector specific primers. In case of Lane 1, primers were having Not1 and BamH1
restriction sites, these enzymes were used to digest and recloned  PCR product again in the vector.
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Fig 21; NIH3T3 cells treated with dexamethasone underwent considerable cell death. Cells
transduced with pOS control vector and pOS vector with any peptide (referred as Neg peptide) exhibited
cell death by dexamethasone treatment for 48h. While cells infected with pOS vector having screened
peptide less cell death was observed compared to other infected cells, inferring that resistivity to
dexamethasone induced toxicity is due to the screened peptide.
Cell proliferation of NIH3T3 cells; Effect of screened peptide
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a
      NIH3T3 cells + Dexamethasone
b
NIH3T3 cells infected with control pOS IRES GFP
vector, treated with  dexamethasone
c
NIH3T3 cells, infected with pOS IRES GFP
vector having recloned screened peptide and
treated with dexamethasone
d
NIH3T3 cells, infected with pOS IRES GFP vector
 having a non specific peptide and treated
 with dexamethasone
e
Fig 23; Photomicrographs of (a) control NIH3T3 cell (b) NIH3T3 cells treated with dexamethasone
(10-4 M) (c) NIH3T3 infected with pOS-IRESGFP vector and treated with dexamethasone (10-4M) (d) NIH3T3
infected with pOS-IRESGFP vector with screened peptide and treated with dexamethasone (e) NIH3T3 infected
with pOS-IRESGFP vector with a negative peptide, treated with dexamethasone post 24h of treatment.
Dexamethasone (10-4 M) caused cell toxicity to a great extent, while cells infected with screened peptide resisted
the toxicity, peptide was screened from the cells infected with peptide library post dexamethasone challenge.
Recloning of this peptide in pOS IRES GFP vector and infecting the vector in NIH3T3 cells showed a
considerable resistance to the dexamethasone induced toxicity. Vector alone and vector with any non-specific
peptide did not showed any resistance to the dexamethasone induced toxicity, emphasizing role of the screened
peptide.
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Fig 24; Photomicrographs of  (a) control NIH3T3 cell (b) NIH3T3 cells treated with Dexamethasone (10-4
M) (c) NIH3T3 infected with pOS-IRESGFP vector and treated with dexamethasone (10-4 M) (d) NIH3T3 infected
with pOS-IRESGFP vector with screened peptide  and treated with dexamethasone (e) NIH3T3 infected with pOS-
IRESGFP vector with a negative peptide and treated with dexamethasone after 48h of treatment . Dexamethasone
(10-4 M) caused cell toxicity to a great extent, while cells infected with screened peptide resisted the toxicity;
peptide was screened from the cells infected with peptide library post dexamethasone challeng. Recloning of this
peptide in pOS IRES GFP vector and infecting the vector in NIH3T3 cells showed a considerable resistance to the
dexamethasone induced toxicity. Vector alone and vector with any non specific peptide did not showed any
resistance to the dexamethasone induced toxicity, emphasizing role of the screened peptide.
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Discussion
Proteins are key players in cellular processes and plays a dominant role in many
biological functions within a cell. Many cellular processes and biochemical events are
achieved by a group of proteins interacting with each other. Protein interactions also had  a
pivotal role in the functional selectivity of enzymes participating in cellular signal
transduction cascades. Interaction between specific binding proteins control, at least in part,
the temporal and spatial orchestration of the functions mediated by these signaling events.
The ability to modulate protein-protein interactions provides a means to elucidate the role of
specific proteins and enzymes in various signaling cascades in normal and diseased states.
Many of the signaling enzymes belong to families of related proteins, each mediating a unique
physiologic functions. Little is known, however, about the role of the individual family
members, mainly due to the lack of selective modulators. One important strategy to search
selective modulators of intracellular signaling enzymes capitalizes on the finding that upon
stimulation many enzymes, including protein kinases, translocate from one cell compartment
to another, which bring proteins close to their activator and /or specific substrates for their
function mediated by selective binding proteins.
Modulation of protein interactions by small molecules (including short peptides)
remains a big challenge. In vivo expression of short specific peptides derived from domains of
one interaction partner could be an approach to alter interaction between two known
interacting protein partners. On expressing short peptides derived from Ros tyrosine kinase
phosphorylation domain in modified cells, expressing PTP SHP-1 and Ros tyrosine kinase
receptor cellular proliferation was successfully modulated. Interaction between tyrosine
kinase Ros and PTP SHP-1 is known to inhibit cell proliferation, growth and differentiation
(Keilhack et al.,2001). Modulation in cell growth was observed only when the receptor from
which the peptides are derived is expressed also along with its interaction partner. A
significant increase in proliferation was observed with peptide that was exact homologues to
the tyrosine phosphorylation domain. Substitution of tyrosine by phenylalanine in the
expressed peptide reduced the observed pro-proliferative effect but did not fully abolish the
proliferation enhancement. Another modification of peptides, addition of two self annealing
flanking clamp sequences on both C and N termini led to reduction of pro-proliferative effect
as exhibited by the peptide with out modification. The idea behind the modification was to
increase the stability of peptides. Self annealing clamp is reported to give a stem loop like
structure (Gururaja et al.,2000) to the expressed peptide that reduces  chances of proteolytic
cleavage and also provides a stable frame to the peptides, but making them less flexible. It
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seems that the rigid structure reduced peptide activity significantly which led to the
speculation that, for pro-proliferative effect peptides should be in less structurally constrained
form and in right frame, to interfere a particular interaction. However, from these
observations it is clear that  small peptides do exert an effect when expressed in vivo. In
normal NIH3T3 cells lacking expression of tyrosine kinase Ros and PTP SHP-1, expressed
peptides showed no effect on enhanced cellular proliferation. This clearly showed that
tyrosine kinase Ros and PTP SHP-1 interaction is influenced by the homologous peptides.
 On analyzing effect of peptides in response to stimulation of the chimeric TrkA-Ros
receptor with NGF, a slight increase in cell proliferation was observed with Pos. However,
relative enhancement by various peptides remained same. This indicates that activation by
NGF uses a signaling mechanism that is complementary to the effect mediated by the
peptides, which led to the suggestion that expression of domain specific peptides directly
influences the activity of the corresponding domain of a target protein. This effect may be
mediated by a direct interaction with other proteins that need to interact with the target protein
(here Ros) for signal transduction. An alternative explanation might be that expression of
homologous peptides interferes with the formation of target protein complexes, which in turn
also affect signal transduction. From these observations it was not clear enough to dissect the
role of in vivo expressed short peptides in Ros-signaling. However, results showed that
expression of short peptides can significantly influence cellular proliferation, based on
specifically influencing the activity of the protein domain from which the peptides are
derived. Addition of the flanking sequence reduced observed enhanced proliferative effect,
probably by hindering the interaction of peptide, thus highlighting significance of proper
frame required for interaction. From these observations it can be summed up that short
peptides can be  expressed in vivo and are able to exert an influence when presented in right
frame. 
Peptides ( LXXLL) as  antagonists of receptor  induced transcription
Transcription factors play an important role in expressing various genes to perform
different cellular functions. VDR, a transcriptional factor and a member of nuclear receptor
(NR) family functions to alter expression of specific genes in response to 1, 25(OH)2D3
(Evans, 1989). NR recruits additional co-modulators to regulated promoters (Rachez et al.,
2000), which involves an activation domain on the receptor and an LXXLL motif within the
comodulator; these factors may function to elicit architectural changes in chromatin structure
essential for enhanced transcription. In response to Vit D, RXR is believed to be a necessary
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partner for VDR to form a heterodimer (Whitfield et al.,1995, Cheskis et al.,1996). VDR
also forms homodimers or heterodimer with RAR. 
LXXLL motif are present in coactivators whose number varies from coactivator to coactivator
are known to interact with AF-2 domain (Hall et al.,2000) of nuclear receptor ligand
complex. An attempt to use LXXLL peptides as antagonists to induced effect was carried out.
Since different coactivators have specific numbers of consensus LXXLL motifs and are
conservely separated from one another, in the present study short peptide with varying
number of motifs and number of amino acid residues around the motif were expressed. Pike
et al.,2003 and  Hall et al.,2002 reported antagonistic property of LXXLL peptides with
different number of motifs, however, for the first time peptides with one LXXLL motif and
with or with out additional flanking residues around the motif were employed to study their
influence on the induced activation. Peptides with additional amino acid residues on both
sides of motif were in format of  X7LX2LLX7 (where L is leucine and X is any amino acid)
which reduces the biasness for any particular amino acid residue. Peptides having additional
residues on both N and C termini of LXXLL motif exhibited better suppressing effect on
activation than peptides lacking additional residues indicating that these residues have a role
in binding and recognizing nuclear receptor to block transcriptional activation induced by Vit
D treatment. Comparing amino acid residues around LXXLL motifs in various coactivators
(Table1), leads to the result that expressed peptides with additional residues bear residual
resemblance with them particularly LX4, it shares residual similarity with the various
coactivators and with so called High affinity peptides (Heery et al.,2001) present in some
strong coactivators which could be the reason for their role in being more potent suppressor
peptide than other peptides. Peptides LX1-LX3 with additional residues has relatively lower
effect than LX 4 peptide. Comparison of flanking amino acid residues of these peptides with
various coactivators showed that they share less residual similarity with them, which could
explain their less effectiveness. It may indicate presence of specific amino acid residues are
important for the interaction and recognition of the AF2 region of the receptor for the peptides
to interact. Peptide LX7 with only two residues on C terminus of motif showed better effect
than peptides lacking residues (LX5 and LX6). Peptide LX7 has amino acid glutamine (Q)
after LXXLL motif which is shared by few high affinity peptides and also by LX4,
implicating presence of a single amino acid residue can have effect in addition to LXXLL
motif. (Hall et al.,2000) reported presence of tryptophan in a peptide as third amino acid
residue before LXXLL motif increases its antagonistic ability.
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 Is antagonistic effect of peptides dependent only on the flanking residues or also on
number and location of LXXLL motifs? Peptide (LX6) was designed with two LXXLL motifs
separated by three amino acid residues without additional residues on both C and N termini of
motif. If the number of motifs were criteria for a peptide to be better antagonist LX6 was the
peptide expected to be more efficient than other peptides. Surprisingly LX6 exhibited less
antagonistic property as indicated by the marker (SEAP) activity than other peptides leading
to the conclusion that number of motifs is not the most important factor for a peptide to act,
especially, if they are close to each other. However, as in most of the coactivator’s position of
LXXLL motifs have conserved spacing (Heery et al.,1997; Torchia et al.,1998) and are
apart from each other. Observed effects from peptide LX6 reconfirms that number of LXXLL
motifs play a role when spaced properly as is case of coactivators. Since, making
oligonucleotides for such long peptide is not practically feasible, no attempt was done to
express long peptide with varying number of motifs conservely spaced. This may suggest that
the AF2 domain where coactivators (LXXLL sequences) interact has a specific binding space
and orientation and interacts efficiently with LXXLL motifs conservely spaced. As mentioned
earlier peptide with only one LXXLL motif (LX5) and with out additional amino acid
residues on C and N termini of motif is employed for the first time for studying effect on
induced transcription. Results are indicating that one motif could act as an antagonist to
induced effect. However, the effect was considerably less than the peptides with additional
residues. This confirms that a single motif can perform the function though not so efficiently. 
In addition to the effect of peptides on vitamin D induced transcription, influence on
dexamethasone and Forskolin induced effects were studied by expressing peptides. Almost in
all treatments peptides with flanking sequences proved to be exerting better effect than non
flanked ones. This demonstrates the importance of amino acid residues around the LXXLL
motif playing  an important role in binding to the AF-2 region of receptor  to act as a strong
antagonist. Interestingly in case of forskolin treatment peptides exerting antagonistic effect
showed considerable variation in their specific effect than observed in dexamethasone and
vitamin D treatment. Peptide LX4 was found to have better antagonistic effect in
dexamethasone and Vit D, while in forskolin treatment peptide LX3 turned out to be efficient
in antagonizing the induced effect. These results indicate peptide affinity varies with
treatment and possibly also with the interacting partner (in present case receptor or other
proteins activated by ligand binding on receptor). On increasing the concentration of peptide
expressing vectors antagonistic effect was found to be concentration dependent, inferring with
Discussion                                                                      68  
higher concentration of peptides possibly more copies of peptides are available to interact
with the receptor to block coactivator recruitment.
Is peptide effect cell line specific?
Is antagonistic effect of peptide is subjected to change in case peptides are expressed
in different cell lines? To answer this, in addition to HeLa cells peptides were expressed in
NIH3T3 cell line. Surprisingly, expressed peptides exert their effects in similar fashion as in
case of HeLa cells with peptides having flanking sequence proving to be better antagonists in
suppressing the induced transcriptional activity caused by various agents like Vit D,
dexamethasone and forskolin. Effect of peptides was also found to be dose dependent as
observed in HeLa cells. Thus, indicating a similar antagonistic effect of peptide in HeLa and
NIH3T3 cells. Although, being two different cell lines, similar behavior of peptide action may
indicate a common mechanism of interaction of ligand binded receptor with coactivators in
both cells, which coincides with observed effect of peptide effect on interaction with activated
receptor when treated with  different transcription inducing agents.
Dexamethasone and forskolin induced cross talk
Glucocorticoids modulate gene expression in mammalian organisms primarily at the
level of transcription although there are reports of post transcriptional effects of
glucocorticoids (Ulbright et al.,1993). Dexamethasone treatment led to CRE mediated
transactivation indicating a possible cross talk of dexamethasone with CRE mediating protein
CREB, as CREB interacts with CRE to initiate the transcription. Glucocorticoids are reported
(Gonzalez et al.,1989; Son et al.,2001; Whitehead et al.,1997) to cause phosphorylation of
CREB , a critical step in its activation. In many cases glucocorticoids are reported to have a
permissive effect on transcription by enhancing ability of cAMP to induce transcription
(Nakamura et al.,1987; Noda et al.,1988). These studies are in agreement with the observed
effect of dexamethasone induced cross talk as confirmed by SEAP activity. However, the
transcriptional activity carried out by CREB on stimulation by dexamethasone is considerably
lower than that from forskolin induced treatment. CREB is known to bind CRE as homodimer
and transcriptional activity is mediated by cAMP dependent protein kinase mediated
phosphorylation (Schmid et al.,1987) which may suggest that CREB phosphorylation by
dexamethasone induction is not sufficient enough to cause the CRE mediated transcription as
caused by forskolin. Dexamethasone is also reported to increase mRNA level of CREB
(Jungmann et al.,1992) in rat C6 glioma cells. Dexamethasone induced transcriptional
activity after cross talk with CREB was found to be suppressed by LXXLL peptides, although
the transcriptional activity as depicted by SEAP activity was less. However, suppression
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pattern of induced cross transactivation by peptides was similar as in case of GRE mediated
transcriptional activity of dexamethasone, with LXXLL peptides having flanking amino acid
residues proving to be more potent in antagonizing than non flanked peptides. Similar cross
transactivation was found in GRE mediated transcriptional activity on treatment with
forskolin. This cross treatment was subjected to suppression by LXXLL peptides indicating
interruption in normal interaction of proteins was responsible for transcriptional activity.
Antagonizing cross talk effect caused by either dexamethasone or forskolin by LXXLL
peptides further proved that LXXLL peptides could be strong antagonists of induced effect if
LXXLL motif in peptides is having additional amino acid residues and bear residual
resemblance with high affinity peptides.
Peptide expression resulted in enhanced anti proliferative effect of dexamethasone, an
effect not observed in Vit D and forskolin treatments. Dexamethasone is known to inhibit cell
growth by blocking progression at G1 phase and also exerting its effect by inhibiting signal
pathways in particular mitogen activated protein kinase (MAPK)  pathway (Lasa et al., 2001;
Reider et al.,1996) There are many reports on the relationship between MAPK and
proliferation e.g. follicle-stimulating hormone has growth stimulatory effect on ovarian
surface epithelial cells, which may be caused by activation of the MAPK (ERK) cascade
(Choi et al.,2002). Phorbol esters inhibit fibroblast growth factor-2-stimulated fibroblast
proliferation by a p38 MAP kinase dependent pathway (Maher P 2002). Previous reports have
suggested the ability of glucocorticoid receptor to suppress transactivation by transcription
factors like AP-1, NF-kB or NFAT as hallmark of glucocorticoid action (Cato et al.,1996;
Barnes, 1998) and p38 kinase as a target for negative regulation by glucocorticoids. However,
p38 activation in HO-8910 cells is reported to get enhanced in a time and dose dependent
manner on dexamethasone treatment (Xia et al.,2003). Antibody array data of MAP Kinases
from peptide expressing cells treated with dexamethasone show considerable decrease in
various proteins involved in MAP kinase pathway, which is consistent with other known data.
Mechanism underlying in down regulating especially ERK1/2 according to (Kassel et al.,
2001) might be via increased expression and decreased degradation of the MAP kinase
phosphatase-1 (MKP-1). However, antibody array data showed an increase in NF-kB, STATs
which are usually down regulated by dexamethasone. An increase in p38 which is negatively
regulated in HeLa cells on dexamethasone was also observed. As p38 is also expressed in
stress conditions, present enhancement may be correlated with stress induced by expressed
peptides, similar can be said of NFkB enhancement. Cross talk between offer an elegant
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approach to study cell surface markers, specific proteins, signal transduction p38 and NF-kB
(McKay et al.,1998) may be also responsible for enhancement in NF-kB expression.
Peptide library screen
A retroviral combinatorial library method based on functional screening of selection of
active peptides expressed in mammalian cells was employed in the present study to screen
peptide preventing dexamethasone induced toxicity. On functional screening of peptide
library in dexamethasone treated cells a peptide was found to provide the cells resistance
against the induced toxicity of dexamethasone. Although the size of screened library was not
so high, it may be possible to screen a library of higher complexity to get a large number of
positive effector peptide. Retroviral vector based transduction ensures stable one cell- one
peptide expression as opposed to other library technologies and allows efficient functional
screening to isolate the desired peptide. Retroviral library approach based on peptide library
has been used by few groups. Xu et al., 2001 reported peptides conferring resistance to taxol
employing peptide library of 18 random acids of higher complexity. Tenson et al.,1997
screened peptides based on retroviral library of 21 amino acids providing resistance to
Erythromycin. Similarly peptides conferring resistance to induced apoptosis were reported by
(Matza-Porges et al.,2003) on screening 15 amino acid random peptide library. Previously,
retroviral library technology has been used in the context of cDNA libraries and in few cases
successful functional cloning of cDNA molecules were reported (Rayer et al.,1994;
Kitamura et al., 1995). Another technology complementary to random peptide library uses
libraries of cDNA fragments, termed genetic suppressor elements for functional screening in
mammalian cells (Holzmayer et al.,1992; Roninson et al.,1995). However in the present
study instead of cDNA libraries, a synthetic nucleotide based library was preferred as the
library components can have any sequence which can be encoded after mixing four
nucleotides and not only sequences already existing in nature, which makes it better candidate
for drug target discovery too. Results from screening of synthetic or phage display peptide
libraries have shown that unnatural higher affinity peptides capable of competing with
naturally occurring protein-protein interactions can be pulled out from random libraries
(Aramburu et al.,1999). Since the size of individual library peptide is in range of 5-20 amino
acids which may suggests that the potential effector peptide may act by blocking crucial
protein-protein interactions via binding directly to localize active sites on their target proteins.
This could be the case with dexamethasone as it blocks cell progression at G1 phase and also
down regulates  signal pathways especially MAP kinase pathways, it may be argued that the
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screened peptide may be able to overcome the dexamethasone mediated effect by acting on
some crucial proteins and interfere with its interaction. Peptide action was further confirmed
on basis on negative controls and vector alone which exerted no effect on the induced toxic
effect by dexamethasone. 
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Summary 
Interaction of proteins is central to various cellular processes like cell growth,
proliferation, differentiation and programmed cell death. The interactions can furthermore be
attributed to specified biochemical processes like transcription, translation or replication
Some proteins are highly specific to interact with certain partners. They also can interact with
many other proteins and even form larger multifunctional complexes. To study the specific
role of a single protein-protein interaction of a multifunctional protein or protein complex, it
is necessary to interrupt each single interaction individually to elucidate their respective role
and influence they exert. 
There are many ways to interrupt protein interactions. One is expressing specific peptides in
vivo to target a known protein-protein interaction. In order to accomplish this, an efficient
retroviral expression vector system capable of expressing peptides was developed. To target
known protein-protein interactions, peptides with sequences homolog to one of the interacting
domains were expressed. As one example, peptides derived from the Ros tyrosine
phosphorylation domain were expressed to target the interaction between the tyrosine kinase
Ros and PTP SHP-1. In a second example peptides based on the LXXLL motif important for
the interaction of transcription factors and coactivators were expressed to disrupt this
interaction. Furthermore, the peptide expression system was used to establish a peptide library
that can be used to screen for new peptides influencing cellular processes. 
The dephosphorylation of tyrosine kinase Ros by PTP SHP-1 is an important step to inhibit
cellular proliferation and growth. To target this interaction, peptides derived from the Ros
tyrosine phosphorylation domain were expressed using retroviral expression system in
modified NIH3T3 cells. These cells express an artificial TrkA-Ros fusion receptor tyrosine
kinase and under the control of anhydrotetracycline expresses PTP SHP-1. Upon expression
of the tyrosine domain homologous peptide an increase in cell proliferation was observed.
Surprisingly, this enhancement in cell growth was independent of PTP SHP-1 and of receptor
stimulation. To exclude that these peptides stimulate proliferation by an independent
mechanism, peptides were also expressed in the unmodified parent NIH3T3 cell line. In this
case no significant stimulation was observed. The peptides only enhanced proliferation in the
presence of the TrkA-Ros receptor containing the homologous domain. A single point
mutation replacing the tyrosine by phenylalanine (negative mutation) significantly reduced
the observed enhancement of proliferation. Modification of peptides by addition of self
annealing complementary flanking sequences at both N and C termini influenced peptide
activity similarly as the replacement of tyrosine. In combination with the negative mutation
(phenylalanine) the self annealing clamps had no observable additional effect. 
Summary 73
The enhanced proliferation observed with the Ros tyrosine domain peptide was not only the
result of a disruption of the Ros SHP-1 interaction. The effect was dependent on the presence
of the cytoplasmic Ros domain, the functional homology and a relative flexibility of the
peptide. Mutation or structural constrain lead to a strong disruption of the proliferation
enhancement.
To address the question if peptides expressed by this system are also active in the nucleus,
transcription factor coactivator interactions were targeted. Ligand binding nuclear receptors
recruit coactivators for full activation in transcription control. Coactivators interact with AF-2
domains of nuclear receptors via consensus LXXLL motifs present in all coactivators. To
interfere with coactivator and receptor interaction short LXXLL peptides with or without
additional amino acid residues around the LXXLL motif were expressed in HeLa and
NIH3T3 cells. Expressed peptides were found to antagonize transcription activation by
various agents like vitamin D, dexamethasone, 9-cis retinoic acid and forskolin. The
antagonizing effect of the peptides increased with additional amino acids around the LXXLL
motif. The inhibitory effect was found to depend on the number of amino acids that an
expressed peptide shares with the high affinity motifs present in strong coactivators when
aligned. Presence of two close LXXLL motifs separated by a few amino acids in a peptide
were less efficient. The peptide with only one LXXLL motif with out additional amino acids
showed the least suppressive effect. These studies demonstrate the importance of
neighbouring amino acid residues around the central LXXLL motif for nuclear receptor
coactivator interaction selectivity. Peptides lacking the LXXLL motif did not show any
antagonistic effect in these experiments.
Comparing transcription induction with the various inducers a pattern of relative specificity
for the various flanking amino acids was found. With this, two main groups are identified, one
containing Vit D, dexamethasone and 9-cis-retinoic acid and the other for forskolin. This
pattern fits well with the known coactivator specificity of the respective transcription factors. 
Finally, a combinatorial retroviral peptide library was synthesized to screen novel bioactive
peptides. The random peptide library was synthesized on the basis of nnk codon system,
where n denotes all four nucleotides and k denotes g and t. This nnk system ensures a more
equal distribution of amino acids in the library and of possible three stop codons two are
omitted. With this system a random retroviral peptide library encoding for peptides of 13
amino acid residues was prepared. After ligation of the template into the retroviral vector a
large number of transformations of E.coli were performed to get at least 106 colonies. Each
colony represented a single vector with a different peptide. All colonies were scrapped and
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used for preparation of vector DNA resulting in a peptide library with about 106 independent
members, all present in a large number of copies. With this expression library new peptides
can be identified in a suitable functional assay. Retroviral infection ensures that in each cell
only one peptide is expressed and present over several generations.
The peptide library was employed to screen bioactive peptides conferring resistance to cells
against dexamethasone induced toxicity. Higher concentration of dexamethasone (10-4 mol/l)
caused considerable cell death of NIH3T3 cells. Using this strategy only one successful
selection could be carried out. Surprisingly, only a single active peptide was identified. Its
activity was reconfirmed after repeated cloning into the retroviral expression system and
subsequent infection suppresses the toxic effect of dexamethasone. How the peptide
influences cellular regulation is not immediately clear and could not be resolved within this
work.
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Zusammenfasung
Wechselwirkungen zwischen Proteinen spielen eine zentrale Rolle in verschiedenen
regulatorischen Prozessen, die das Zellwachstum, die Vermehrung, Differenzierung und
programmierten Zelltod (apoptose) steuern. Auch beim Blick auf biochemischen Prozessen,
wie z.B. Transkription und Translation, spielen Protein-Protein-Interaktionen eine
entscheidende Rolle. Proteine zeigen eine sehr hohe Spezifität bei der Interaktion mit
Partnermolekülen. Sie können darüberhinaus meist mit vielen anderen Proteinen interagieren
und multifunktionelle Komplexe bilden. Um die spezifische Rolle einer Protein-Protein-
Interaktion innerhalb eines multifunktionellen Proteins oder Komplexes zu untersuchen, ist es
erforderlich, jede Interaktion innerhalb des Komplexes individuell beeinflussen zu künnen.
Protein-Wechselwirkungen können durch verschiedene Methoden unterbrochen
werden. Eine Möglichkeit bietet die Expression von Peptiden, die gegen spezifische Protein-
Protein-Interaktionen gerichtet sind. Dazu wurde im Rahmen der vorliegenden Arbeit ein
effizientes Expressionssystem für die kontrollierte Expression kleiner Peptide auf Basis von
retroviralen Vektoren entwickelt. In einem ersten Schritt wurde dieses System genutzt, um
bekannte Protein-Protein-Interaktionen zu beeinflussen. Dazu wurden Peptide exprimiert, die
mit einer der interagierenden Domänen homolog sind und daher die entsprechende Interaktion
kompetitiv unterbinden sollten. Zum einen wurde die Tyrosin-Phosphorylierungsdomäne von
Ros genutzt, um die Interaktion der Ros-Tyrosin-Kinase mit der Phosphatease SHP-1 zu
beeinflussen, zum anderen Peptide mit LXXLL-Motiven, um entsprechender Weise die
Interaktion von Transkriptionsfaktoren und Koaktivatoren zu unterbinden. Darüber hinaus
wurde ein System zur Expression einer Peptid-Bibliothek entwickelt, die es ermöglicht nach
neuen Peptiden zu suchen, die zelluläre Prozesse beeinflussen.
Die Dephosphorylierung von Ros durch SHP-1 Phosphatase ist ein wichtiger Schritt
zur Inhibierung zellulärer Proliferation und Wachstum.  Um dies zu untersuchen, wurden die
Ros-abgeleiteten Peptide mit dem retroviralen Expressionssystem in einer modifizieten
NIH3T3 Zelllinie exprimiert. Diese Zellen enthalten einen artifiziellen TrkA-Ros Rezeptor
und können auch SHP-1 unter Kontrolle von Tetrazyklin exprimieren. Durch Expression der
zur Tyrosin-Domäne homologen Peptide wurde eine signnifikante Zunahme der Proliferation
beobachtet. Überraschender Weise war diese unabhängig von SHP-1 und der Aktivierung des
Rezeptors. Um auszuschließen, daß die Peptide über einen anderen Mechanismus die
Proliferation stimulieren, wurden diese auch in nicht modifizierten NIH3T3 Zellen exprimiert.
Dabei konnte keine nennenswerte Stimulierung beobachtet werden. Die Peptide waren nur
proliferationsfördernd, wenn der TrkA-Ros Rezpetor mit der homologen Domäne in den
Zusammenfassung                                                           76  
Zellen exprimiert wurde. Das Ersetzen des funktionellen Tyrosins durch Phenylalanin im
Peptid (negative Mutation) führte zu einer deutliche Abschwächung der
Proliferationsförderung. Eine weitere Veränderung der vom Rezeptor abgeleiteten Peptide
durch Hinzufügen von selbst-bindenden („self-annealing“) komplementären flankierenden
Sequenzen an N- und C-Terminus führte zu einer vergleichbaren Verminderung der
Proliferationsförderung wie das Ersetzen des Tyrosins durch Phenylalanin. In Verbindung mit
der negativen Mutation (Phenyalanin) hatten die selbst-bindenden flankierenden Sequenzen
jedoch keinen zusätzlichen Effekt. 
Die durch das Ros-Tyrosin-Domäne-homolge Peptid erhöhte Zellproliferation konnte
nicht auf einer Störung der Wechselwirkung zwischen Ros und der SHP-1 Phosphatase
zurückgeführt werden. Der Effekt ist jedoch abhängig von der Anwesenheit der
cytoplasmatischen Ros Domäne, der funktionellen Homologie und einer relativen Flexibilität
des Peptides. Mutation oder strukturellen Rahmen führten dagegen zu einer starken
Abschwächung der Proliferationsförderung. 
Mit dem gleichen Vektorsystem wurden auch Peptide mit-einem LXXLL Motiv
exprimiert, um zu überprüfen ob mit diesem System auch Interaktionen im Zellkern
beeinflußt werden können. Das LXXLL Motiv ist sehr charakteristisch für Koaktivatoren von
Transkriptionsfaktoren und spielt eine Rolle bei der Wechselwirkung eines Koaktivators mit
der AF-2-Transaktivierungs-Domäne eines aktivierten nukleären Rezeptors. Peptide mit oder
ohne zusätzliche Aminosäuren um das LXXLL Motiv, exprimiert in HeLa und NIH3T3
Zellen, wirkten der Trankriptionsinduktion durch verschiedene induzierende Moleküle wie
Vitamin D, Dexamethason, 9-cis Retinolsäure und Forskolin entgegen. Der antagonistische
Effekt war bei Peptiden mit flankierenden Aminosäuren stärker als bei Peptiden ohne
zusätzliche Aminosäuren. Die beobachteten Effekte waren auch von der Anzahl und Lage der
Aminosäuren um das Motiv abhängig und um so effektiver, je besser diese mit natürlichen
Nachbaraminosäuren in LXXLL Motiven starker Koaktivatoren übereinstimmten. Zwei nah
beeinander liegende LXXLL Motive hatten einen geringeren inhibierenden Effekt. Peptide
mit nur einem LXXLL Motiv zeigten im Vergleich die geringste Aktivität. Diese
Beobachtungen verdeutlichten die Bedeutung zusätzlicher Aminosäuren um das LXXLL
Motiv für die Wechselwirkung mit nukleären Rezeptoren und Transkriptionsfaktoren. Peptide
ohne  LXXLL Motiv hatten keinen antagonistischen Effekt.
In Vergleich der Trankriptionsinduktion durch die verschiedenen Induktoren, konnte
darüber hinaus eine Zuordnung der relativen Spezifität für die unterschiedlichen
flankierenden Aminosäuren gefunden werden. Dabei entstehen zwei Hauptgruppen, eine mit
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Vitamin D und Dexamethason, die andere mit Forskolin, welche gut zur bekannten
unterschiedlichen Koaktivatorspezifität der jeweils aktivierten Transkriptionsfaktoren passt. 
 Neben der Expression bekannter Peptide wurde das retrovirale Expressionssystem
auch genutzt um eine retrovirale Peptid-Expressionsbibliothek herzustellen. Die
Peptidbibliothek wurde auf der Basis von NNK Kodons generiert, wobei N für alle vier
Nukleotide steht während K nur für G und T codiert. Durch das NNK-System wird eine
bessere Verteilung von Aminosäuren erreicht und zwei von drei Stopkodons eliminiert. Mit
diesem System wurde eine retrovirale randomisierte Peptidbibliothek mit Peptiden von 13
Aminosäuren Länge generiert. Nach Ligation wurden durch wiederholte Transformation mehr
als 106 Kolonien erhalten, die jeweils einen Vektor mit einem unterschiedlichen Peptid
enthalten. Alle Klone wurden in die Präparation von Vektor-DNA eingesetzt und so eine
Bibliothek von ungefähr 106 unabhängigen Peptiden erhalten. Die sind wiederum in großer
Kopienzahl vorhanden. Mit dieser Expressionsbibliothek wird es möglich, in einem
geeigneten zellulären Funktionsassay nach neuen Peptiden zu suchen. Durch die retrovirale
Infektion wird sichergestellt, daß jede Zelle jeweils nur ein Peptid exprimiert und die
Expressionskassetten über mehrere Generationen an Tochterzellen weitergibt. 
Als Selektionsstrategie wurde der cytotoxische Effekt von Dexamethason genutzt.
Erhöhte Konzentration von Dexamethason (10-4 mol/l) führte zu einem signifikantem
Absterben von NIH3T3 Zellen. Im Rahmen der Arbeit konnte nur eine erfolgreiche Selektion
durchgeführt werden. Diese führte überraschend zur Selektion nur eines einzigen aktiven
Peptids. Dessen Aktiviät konnte, auch nach erneuter Klonierung in das retrovirale
Expressionssystem und anschließender erneuter Infektion, den cytotoxischen Effekt von
Dexamethason unterdrücken. Wie das Peptid in die zelluläre Regulation eingreift, konnte
leider bis zum Abschluß dieser Arbeit nicht geklärt werden.
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